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V(D)J recombination is initiated by a specialized transposase consisting of the 
subunits RAG-1 and RAG-2. The susceptibility of gene segments to DNA cleavage by 
the V(D)J recombinase is correlated with epigenetic modifications characteristic of active 
chromatin, including trimethylation of histone H3 on lysine 4 (H3K4me3). Engagement 
of H3K4me3 by a plant homeodomain (PHD) in RAG-2 promotes recombination in vivo 
and stimulates DNA cleavage by RAG in vitro. We characterized features of this PHD-
mediated inhibitory domain and identified a second, independent, inhibitory domain. 
Mutation of this second inhibitory domain allows bypass of the requirement for 
engagement of H3K4me3 by the RAG-2 PHD. Disruption of this inhibitory domain was 
associated with constitutive increases in recombination frequency, DNA cleavage 
activity, substrate binding affinity, and catalytic rate. We further characterized this 
domain genetically and determined that the inhibitory function is imposed by acidic 
residues between residues 352 and 405. Further, we were able to demonstrate that the 
inhibitory domain mutation is refractory to removal of the entire noncore portion of 
RAG-2. Therefore, this inhibitory domain acts independently of the PHD. Inactivation of 
the inhibitory domain confers a gain-of-function recombination phenotype and permits 
rearrangement at endogenous IgH and Igκ loci in the absence of H3K4me3 binding. In B 
progenitor cells, localization of wild-type RAG-2 to the IgH locus and actively 
transcribed loci is abolished by the W453A mutation, indicating that this pattern of 
chromatin localization is dependent on recognition of H3K4me3. This same mutation 
also abolishes association of RAG-1 with the IgH locus. Strikingly, disruption of the 
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inhibitory domain permits association of RAG-2 and RAG-1 with the IgH locus even in 
the absence of H3K4me3 engagement by RAG-2. Thus, the RAG-2 inhibitory domain 
serves as a binary gate that permits the association of RAG-1 and RAG-2 with chromatin 
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Adaptive immunity and receptor rearrangement 
The adaptive immune system is characterized by its ability to specifically 
recognize a diverse spectrum of epitopes. Separately encoding this diversity would 
require a trillion base pairs, three times the number in the entire haploid mouse genome. 
The adaptive immune system solves this coding paradox by assembling antigen receptors 
from discrete DNA segments. For example, at the immunoglobulin heavy chain (IgH) 
locus in mice, there are approximately 110 functional variable (V) segments (Johnston et 
al. 2006), 10-13 diversity (D) segments (Ye 2004), and 4 joining (J) segments. These 
gene segments are each flanked by at least one recombination signal sequence (RSS) that 
is recognized by a complex of recombination activating genes 1 and 2 (RAG-1 and RAG-
2). RSSs are composed of a conserved nonamer and heptamer separated by a spacer of 12 
bp or 23 bp, termed 12-RSS and 23-RSS respectively. The RAG recombinase participates 
in all stages of V(D)J recombination, from RSS binding and synapsis of the gene 
segments, to cleavage and repair of the resulting double-strand breaks (DSBs). 
Expression of RAG-1 and RAG-2 is restricted to developing lymphocytes, however 
regulation of the antigen receptor loci prevents inappropriate recombination, even in the 
presence of RAG (Stanhope-Baker et al. 1996). 
Antibodies, generated by B-cells, are composed of four polypeptides: two 
identical heavy chains and two identical light chains encoded by either the 
immunoglobulin κ (Igκ) or immunoglobulin λ (Igλ) loci. Disulfide bonds anchor the light 
chains to the heavy chains and connect the heavy chains to each other to form the 
characteristic “Y” structure of antibodies. T-cell receptors (TCRs) are heterodimers 
formed by recombination of the TCR α and β or ɣ and δ loci. B- and T-cells are clonal in 
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that each cell expresses only one of the billions of possible receptors. The importance of 
the adaptive immune system is illustrated in the disease phenotypes associated with a loss 
of V(D)J recombination. There is no redundancy in RAG function, therefore inactivating 
mutations result in a severe combined immunodeficiency (SCID) phenotype, marked by a 
complete lack of mature lymphocytes. Hypomorphic RAG alleles that retain some 
recombination activity result in Omenn syndrome, which is characterized by the absence 
of B-cells and oligoclonal, autoreactive T-cells (Villa et al. 2001). 
Chromosomes are extended DNA molecules that must be accommodated in the 
relatively small nucleus of the cell in an ordered and dynamic structure that allows access 
to necessary information. This is accomplished by compacting DNA into nucleosomes. 
Each nucleosome consists of 146 bp of DNA wrapped around the histone core, composed 
of two molecules each of H2A, H2B, H3, and H4. Between these core nucleosome 
assemblies is linker DNA that can be further compacted by linker histones including H1. 
Nucleosomes and higher order structures can compact DNA more than 1,000-fold in 
dividing cells. Histones can be extensively modified and these modifications can be 
specifically recognized by a variety of protein domains. 
 
The RAG recombinase 
RAG-1 and RAG-2 form a “Y” shaped heterotetramer with two intertwined RAG-
1 monomers forming the base and a RAG-2 monomor upon each (Kim et al. 2015; 
Grundy et al. 2009). RAG-1 is 1040 amino acids long, however only the region from 384 
to 1008 is required for catalysis (Silver et al. 1993; Kirch et al. 1996; Sadofsky et al. 
1993). The nonamer binding domain (NBD), from residue 391 to 459, binds the 
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conserved nonamer of the RSS. This domain adopts a three-helix structure that forms 
extensive hydrophobic contacts with another RAG-1 NBD to form a homodimer. The 
homodimer engages two RSS nonamers through extensive minor groove contacts, 
marginal major groove contacts, and interactions with the backbone of the spacer (Fang 
Yin et al. 2009; Kim et al. 2015). The two RAG-1 monomers are intertwined such that 
the NBD of one monomer interacts with the RSS that will be cleaved in the active site of 
the other monomer (Swanson 2001). A flexible linker connects the NBD to the 
dimerization and DNA binding domain (DDBD) that is highly positively charged and 
may, in collaboration with high mobility group box 1 (HMGB1) stabilize the kink in the 
RSS that facilitates cleavage (Kim et al. 2015). HMGB1 is a sequence non-specific DNA 
binding and bending protein that stimulates RAG binding to the 23-RSS and stabilizes 
DNA bending at the 12-RSS heptamer (Zagelbaum et al. 2016). RAG-1 adopts an RNase 
H fold that forms the catalytic site with D600, D708, and E962 (DDE motif). Mutation of 
the DDE motif abolishes catalytic activity while sparing RSS binding (Kim et al. 1999). 
Zinc is coordinated by two histidines and two cysteines. While core RAG-1 contains the 
portion of the protein minimally required for recombination, there is evidence that the 
noncore regions of RAG-1 contribute to recombination in vivo (Liang et al. 2002).  
 Concurrent investigations of the noncore regions of RAG-1 identified putative E3 
ligase activity (Yurchenko et al. 2003; Jones & Gellert 2003) within the Really 
Interesting New Gene (RING) finger domain N-terminal of the RAG-1 core. In short, 
ubiquitination begins with a general ubiquitin-activating enzyme (E1) after which the 
activated ubiquitin is transferred to a ubiquitin-conjugating enzyme (E2) which works 
with the specific ubiquitin-protein ligase (E3) to attach ubiquitin to a lysine residue in the 
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target substrate (Laney & Hochstrasser 1999). RAG-dependent ubiquitin uptake has been 
observed in the presence of various E2 ligases (Yurchenko et al. 2003; Jones & Gellert 
2003). The RAG-1 RING domain was shown to bind to (Cortes et al. 1994) and 
ubiquitinate (Simkus, Makiya, et al. 2009) karyopherin alpha 1 (KPNA1), an importin 
subunit. There is additional evidence of autoubiquitination (Jones & Gellert 2003; Singh 
& Gellert 2015) and RAG-dependent histone H3 ubiquitination (Grazini et al. 2010; 
Jones et al. 2011; Deng et al. 2015). Interestingly, a complex of proteins that co-purifies 
with full length RAG-1, termed the VDCR complex (VprBP, DDB1, Cul4A, and Roc1) 
exhibited ubiquitination activity that was stimulated by RAG-1 and conditional VprBP 
deletion resulted in recombination defects (Kassmeier et al. 2012). Purified, ubiquitinated 
RAG-1 exhibits increased basal activity (Singh & Gellert 2015) and mutations that 
impaired E3 ligase activity were associated with decreased recombination frequency 
(Simkus, Bhattacharyya, et al. 2009). There are also cases of Omenn syndrome resulting 
from mutations in the RING domain (Villa et al. 2001; Simkus et al. 2007; Deng et al. 
2015). Taken together, these data support a role for noncore RAG-1 in recombination, 
however the nature of this role is still unclear. 
 
RAG-2 
RAG-2 is 527 amino acid residues long. Only the N-terminal 387 amino acids, 
termed the core region, are required for RSS cleavage in vitro (Sadofsky et al. 1994; 
Cuomo & Oettinger 1994), but removal of the noncore region, comprising residues 388 
through 527, is associated with decreased recombination frequency (Steen et al. 1999) 
and increased aberrant recombination in vivo (Sekiguchi et al. 2001; Akamatsu et al. 
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2003). Core RAG-2 consists of six kelch-like repeats that fold into a β-propeller structure 
with extended loops that interface with the zinc coordinating and RNase H domains of 
RAG-1 (Kim et al. 2015; Callebaut & Mornon 1998). These extensive contacts may 
explain the requirement of RAG-2 for efficient recombination despite RAG-1 containing 
the important catalytic and DNA binding residues. The noncore region of RAG-2 serves 
several regulatory functions, including cell cycle-dependent degradation (Jiang et al. 
2005; Lee & Desiderio 1999; Li et al. 1996; Zhang et al. 2011; Lin & Desiderio 1994), 
nuclear import (Ross et al. 2003), recognition of H3K4me3 (Liu et al. 2007; Matthews et 
al. 2007; Ramón-Maiques et al. 2007), and autoinhibition (Lu et al. 2015). 
While RAG-1 protein levels are steady throughout the cell cycle, RAG-2 
expression is regulated dynamically. Threonine 490 (T490) is phosphorylated by cyclin 
A/CDK2 (Lin & Desiderio 1993), and this phosphorylation leads to ubiquitination by the 
Skp2-SCF E3 ligase. Polyubiquitination of RAG-2 leads to proteasomal degradation 
(Jiang et al. 2005) before cells enter S phase, which restricts recombination to G0/G1 (Lin 
& Desiderio 1994). RAG-2 bearing the point mutation, T490A, persists throughout the 
cell cycle (Li et al. 1996), and is associated with genomic instability and, in p53-deficient 
mice, lymphomagenesis (Zhang et al. 2011). This was recapitulated with core RAG-2 
mice on a p53-null background (Chaumeil et al. 2013), however the noncore region 
serves multiple functions that confound analyses of core RAG-2 mice. The transcription 
factor, p53, is phosphorylated by proteins involved in repair of RAG-mediated breaks and 
its activation leads to cell cycle arrest, preventing cell cycle progression until RAG-
mediated breaks have been repaired (Helmink & Sleckman 2012). Multiple mechanisms 
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ensure that RAG-mediated breaks are only generated in G0/G1 and resolved prior to 
initiation of S-phase. 
RAG-2 contains a plant homeodomain (PHD), spanning residues 415 through 
487, that binds histone H3K4me3 (Liu et al. 2007; Matthews et al. 2007; Ramón-Maiques 
et al. 2007). The RAG-2 PHD has a hydrophobic channel that accommodates the 
H3K4me3 side chain, coordinating the trimethyl ammonium with the conserved residue 
tryptophan 453 (W453) (Ramón-Maiques et al. 2007). A point mutation of W453 ablates 
the ability to bind to H3K4me3 (Ramón-Maiques et al. 2007; Matthews et al. 2007; Liu 
et al. 2007), impairing recombination on chromatinized substrates and at endogenous loci 
while sparing in vitro activity (Matthews et al. 2007; Liu et al. 2007). RAG-2 localization 
appears to be mediated largely or wholly by the PHD, as RAG-2 binds broadly across the 
genome in a pattern that is correlated with sites of H3K4me3 deposition. Further, this 
localization is independent of RAG-1 coexpression. RAG-1, by contrast, binds 
specifically to antigen receptor loci and can bind to all but the IgH locus in the absence of 
RAG-2 (Ji et al. 2010). A patient with Omenn syndrome was identified with a W453R 
mutation, underscoring the importance of the PHD function to recombination (Gomez et 
al. 2000). 
 
Mechanism of V(D)J recombination 
There are two classes of RSS, termed 12-RSS and 23-RSS, composed of 
conserved nonamer (5’-GGTTTTTGT) and heptamer (5’-CACAGTG) elements (Sakano 
et al. 1979) separated by spacers of 12 bp or 23 bp, respectively (Akira et al. 1987). 
Rearrangement proceeds in the following sequence: (1) capture by RAG of a 12-RSS and 
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a 23-RSS, resulting in synapsis of participating gene segments; (2) nicking by RAG at the 
junction between each gene segment and its flanking RSS; (3) transesterification to 
produce double-strand breaks; and (4) joining of the participating gene segments by 
classical non-homologous end joining (cNHEJ) (Gellert 2002; Deriano & Roth 2013). It 
is still unclear whether RAG-1 and RAG-2 form a complex that scans for appropriate 
substrates or if the RAG complex is assembled at the target RSS (Askary et al. 2014). 
RAG-1 does bind to most antigen receptor loci in the absence of RAG-2 and RAG-2 
binds promiscuously to genomic H3K4me3 in a RAG-1-independent manner (Ji et al. 
2010). Therefore, a parallel binding model must also account for the individual binding 
activities of the two RAG subunits. While RAG is capable of nicking at a single RSS in 
vitro (Yu & Lieber 2000), modeling suggests that synapsis precedes nicking and that 
synaptic complex formation is essentially irreversible (Askary et al. 2014). The cleavage 
mechanism is a two-step process whereby RAG first induces a single strand nick at the 5’ 
end of the RSS, between the heptamer and coding sequence. The free hydroxyl attacks 
the opposite strand to create a hairpin coding end and a blunt 5’ phosphorylated signal 
end (McBlane et al. 1995). Breaks are then resolved in collaboration with cNHEJ 
machinery. 
Heptamer and nonamer sequences of the RSSs are well conserved and some 
mutations are prohibitive to hairpin formation. This can be ameliorated by base-
unpairing, which suggests that the ability of RAG to unpair the sequence, rather than the 
identity of the sequence, determines recombination competency. There are distinct 
requirements for the different steps of catalysis. RAG binding is largely guided by the 
nonamer sequence, however nicking and hairpin formation rely primarily on the 
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heptamer. Nick generation is not dependent on the first two nucleotides of the heptamer, 
however hairpin formation is. Modeling shows that RAG can discriminate between 
appropriate recombination targets, those with an intact RSS and permissive euchromatin, 
and inappropriate targets lacking either of these features (Askary et al. 2014). This 
fidelity of substrate recognition is vital to maintaining genomic integrity. 
 
The 12/23 rule 
RAG exhibits a 50-fold preference for a synaptic complex containing one 12-RSS 
and one 23-RSS, a generalization termed the 12/23 rule. Enforcement of the 12/23 rule 
helps to prevent homotypic recombination amongst two of the same gene segment. The 
difference between a 12- and 23-RSS is approximately one helical turn of B-form DNA. 
This opens the possibility that the 12/23 rule is enforced, in part, by a helical phase 
requirement for RAG activity. This is supported by the finding that increasing the spacer 
length by one half-turn is more detrimental than increasing the spacer length by a whole 
helical turn (Ramsden et al. 1996). In vitro 12/23 specificity is improved by addition of 
HMGB1, which also stimulates recombination (van Gent et al. 1997). Free RAG 
heterotetramers are symmetric (Kim et al. 2015), however binding a 12- and 23-RSS will 
inherently induce asymmetry because the dimerized NBD domains both tilt towards the 
shorter 12-RSS. Cryo-electron microscopy experiments suggest that this asymmetry in 
RSS binding enforces the 12/23 rule, because a shorter 12-RSS means that a longer 23-
RSS is required to make up for the tilt (Ru et al. 2015). The role of HMGB1 in creation 
and maintenance of these DNA bends, provides a molecular hypothesis explaining how 
HMGB1 aids in enforcement of the 12/23 rule. Further, stabilization of the bent DNA 
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conformation can mechanistically explain the effect of HMGB1 on the catalytic rate of 
the V(D)J recombinase. 
While permitted by the 12/23 rule, V segments at the IgH and TCRβ loci do not 
typically recombine to J segments. This restriction, termed beyond 12/23, likely ensures 
that D segments are used. At the TCRβ locus, it was found that the Dβ1 12-RSS is 
inherently predisposed to recombine with the Vβ 23-RSS. Similarly, the Vβ 23-RSS 
would not recombine with Jβ 12-RSS. Beyond 12/23 regulation appears to be a sequence-
dependent, position-independent phenomena (Bassing et al. 2000) that ensures each chain 
includes the appropriate gene segments. 
 
Classical repair of RAG-mediated breaks 
 The hairpin coding ends and blunt signal ends formed by RAG-mediated cleavage 
remain stably associated with RAG in a post-cleavage complex. This is hypothesized to 
ensure that RAG-mediated breaks are funneled into the cNHEJ repair pathway. The Ku 
heterodimer, composed of Ku70 and Ku80 subunits, is highly abundant in cells and 
exhibits a high affinity for DNA breaks, including blunt ends, overhangs, and covalently 
sealed hairpins. Evidence suggests that Ku associates with noncore RAG-1, which may 
be one of the links between RAG cleavage and repair (Raval et al. 2008). Ku forms a ring 
that encircles DNA and translocates on the DNA strand to allow more Ku dimers to bind 
and coat DNA ends. Ku recruits DNA-PKCS and further translocates to open up DNA 
ends to DNA-PKCS. DNA-PKCS bound to Ku and DNA ends is considered a holoenzyme 
that can then phosphorylate itself and many targets involved in DSB repair (Deriano & 
Roth 2013). While many substrates have been identified, including Artemis, Ku, the 
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histone variant H2AX, XRCC4, Ligase IV, and XLF, individual mutational analyses 
reveal redundancy. The Ku complex is required for efficient resolution of both coding 
and signal ends. While DNA-PKCS is essential for coding joint formation, signal joint 
formation is only mildly impaired by its absence. This is likely due to functional 
redundancy with ataxia telangiectasia mutated (ATM), as double mutants have severe 
defects in signal joint formation (Gapud & Sleckman 2011). Artemis has basal 5’ to 3’ 
exonuclease activity, however DNA-PKCS activates endonucleolytic activity that enables 
Artemis to hydrolyze the phosphodiester bonds covalently sealing the coding hairpins. 
Opening at the apex could lead to a flush coding joint with no gain or loss of nucleotides. 
Conversely, an asymmetric nick results in palindromic (P) nucleotides. The RAG 
complex can nick hairpin coding joints via sequence non-specific endonuclease activity 
that uses the same active site as recombination. This activity is associated with formation 
of coding joints with long P insertions (Besmer et al. 1998; Shockett & Schatz 1999). 
Efficient repair of both signal and coding ends requires XRCC4 and DNA Ligase 
IV. DNA Ligase IV, in complex with XRCC4 and XLF/Cernunnos, ligates RAG-
mediated breaks. XRCC4 stabilizes DNA Ligase IV, stimulates the first step in ligation, 
and may align DNA ends (Helmink & Sleckman 2012). Further, XRCC4 interacts with 
polynucleotide kinase/phosphatase which promotes DNA ligation by phosphorylating 5’-
hydroxyl groups and dephosphorylating 3’ phosphates to generate compatible ends. XLF 
and XRCC4 form filamentous structures that could function to bridge DSB gaps (Deriano 
& Roth 2013). MRE11, Rad50 and Nbs1 form the MRN complex, which activates ATM, 
initiates end resection, and tethers broken DNA ends. Once ATM is activated, it 
phosphorylates factors involved in DSB repair, including H2AX. ATM also 
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phosphorylates p53, which ties cell cycle progression to resolution of RAG-mediated 
DSBs. The phosphorylated form of histone variant H2AX, termed ɣ-H2AX, protects 
RAG induced DSBs from extensive end resection. Loss of ɣ-H2AX does not impair 
recombination, likely due to redundancy of some functions shared with XLF. 
Terminal deoxynucleotidyltransferase (TdT) adds (N) nucleotides to 3’ DNA ends 
in a template-independent manner. In V(D)J recombination, these N additions on coding 
ends increase junctional diversity (Helmink & Sleckman 2012). N and P nucleotides 
increase the variability of antigen receptors, even when the same gene segments are used. 
Signal ends are generally ligated without the additional processing steps, creating a flush 
joint between the heptamers of the 12- and 23-RSSs. 
 
Alternative repair mechanisms 
 While RAG-mediated breaks are generally repaired in collaboration with the 
cNHEJ machinery, some evidence suggests that impairment of cNHEJ funnels DSBs into 
a distinct pathway called alternative non-homologous end joining (altNHEJ). Junctions 
repaired by altNHEJ frequently exhibit large deletions, microhomology, and large 
insertions of unknown origin. While relatively little is known about altNHEJ, it is thought 
to begin with extensive end resection and end with ligation by DNA Ligase III. In 
altNHEJ, Poly(ADP-ribose) polymerase 1 (PARP1) binds DNA analogously to and in 
competition with Ku. MRE11 has been implicated in the extensive end resection, and 
CtIP can open coding end hairpins in the absence of Artemis. altNHEJ may function in 
cNHEJ-sufficient cells as well, operating at one tenth the frequency of cNHEJ. It is 
difficult to determine whether altNHEJ represents a distinct pathway or functional 
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redundancy in cNHEJ. The features of junctions formed by altNHEJ are similar even 
when the deficiencies are in different parts of cNHEJ, which provides some evidence that 
altNHEJ represents a distinct pathway (Deriano & Roth 2013). However, the features that 
characterize altNHEJ are not unique, as cNHEJ frequently uses 1-2 bp of microhomology 
(Pannunzio et al. 2014). Further work will be required to determine whether cNHEJ 
adapts to deficiencies or if cNHEJ deficiencies funnel DSBs to a distinct, more error 
prone, pathway. 
It is currently unclear what role the RAG complex plays in repair during V(D)J 
recombination. XLF is not strictly required for V(D)J recombination, however its 
deletion impairs cNHEJ in other contexts. This suggests that the function of XLF is 
partially redundant with a factor specific to V(D)J recombination. Both XLF null and 
core RAG-2 mice exhibit only mild reduction in T lymphopoesis, however crossing the 
two lines exacerbates this phenotype. The double mutant mice have impaired V(D)J 
recombination and resultant lymphopenia. This implicates the noncore region of RAG-2 
in the ability to bypass XLF-deficiency, suggesting functional redundancy (Lescale et al. 
2016). A RAG-2 frameshift mutation, RAG-2(FS361), results in 28 novel amino acids 
before a stop codon and elimination of the noncore regions of RAG-2. Mice expressing 
this variant are predisposed to lymphoma on a p53-null background, consistent with the 
evidence that cell-cycle regulation in noncore RAG-2 prevents genomic instability. 
However this mutation also allowed bypass of DNA-PKCS and XRCC4 deficiencies, with 
junctions that bear hallmarks of altNHEJ (Corneo et al. 2007). Both this frame shift 
mutation and a truncation of RAG at 352 increased aberrant recombination and allowed 
bypass of Ku-deficiency (Gigi et al. 2014). Further, mutation or deletion of the acidic 
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hinge region of RAG-2 may predispose cells to use of altNHEJ, allowing bypass of 
deficiencies in classical NHEJ. Neutralization or deletion of the acidic hinge increased 
the appearance of aberrant metaphases, suggesting that the region is important to proper 
repair of RAG mediated lesions (Coussens et al. 2013). This acidic hinge region is similar 
to the inhibitory domain identified in studies below that can bypass the detrimental 
W453A mutation (Lu et al. 2015), which opens the possibility that the region could be 
important to both cleavage and repair. Taken together, these data implicate the C-
terminus of RAG-2 in repair of RAG-mediated breaks through a not yet understood 
mechanism. 
 Cell-cycle dependent regulation of RAG-2 protein accumulation has implications 
on the mode of coding end repair. cNHEJ is active throughout the cell cycle, however 
homologous recombination (HR) predominates after S-phase, when a homologous 
chromosome is available for template-dependent repair. Mistimed repair of RAG-
mediated breaks is associated with complex chromosomal translocations (Zhang et al. 
2011) consistent with abortive iterations of break induced replication. Break induced 
replication in eukaryotic cells is not well studied, but involves strand invasion followed 
by establishment of an illicit replication fork (Malkova & Ira 2013). The result of this 
replication depends on the template used for repair: sister chromatids result in faithful 
repair; homologous chromosomes result in a loss of heterozygosity; and heterologous 
chromosomes result in non-reciprocal translocation. Tandem duplications arise in 
junctions of RAG-2(T490A) mice, which implies the use of a replicative repair 
mechanism. Thus, in addition to genetic interactions with repair factors, the noncore 
region of RAG-2 enforces timing of RAG activity that prevents involvement of HR. 
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Developmental regulation of V(D)J recombination 
While a 12-RSS and 23-RSS are sufficient to support DNA cleavage by RAG in 
vitro, V(D)J recombination in vivo is subject to higher level constraints that restrict 
rearrangement to particular sets of gene segments in distinct lymphocyte lineages and 
developmental stages. Addition of RAG complexes to isolated nuclei from a given 
lymphoid cell type results in recombination of only the developmentally appropriate 
receptor (Stanhope-Baker et al. 1996). That is, the context of the antigen receptor loci 
determines which will recombine. In early B-cell development, the IgH and Igκ loci 
move from the nuclear periphery to a more central and accessible location (Kosak et al. 
2002). Rearrangement is initiated first at the IgH locus. Within the IgH locus, DH-JH 
joining occurs on both alleles (Coleclough et al. 1981) and precedes recombination of a 
VH segment to the DH-JH unit (Alt et al. 1984). The cell initially expresses this V(D)J 
product with a pair of surrogate light chains. Approximately two-thirds of the 
rearrangements are unproductive (Coleclough et al. 1981), in which case the second allele 
is rearranged. Upon productive rearrangement and expression of immunoglobulin µ 
chain, further recombination at the IgH locus is suppressed and rearrangement of light 
chain loci is initiated (Jung et al. 2006). This transition is associated with epigenetic 
changes at the Igκ locus and delayed changes at the Igλ locus, providing a plausible 
explanation for the observation that Igκ generally recombines prior to Igλ (Goldmit et al. 
2005; Xu & Feeney 2009). Recombination is an ordered process that is highly regulated 
during lymphocyte development. 
V(D)J recombination is invariably preceded by sterile germline transcription from 
promoters whose activity is positively correlated with rearrangement (Van Ness et al. 
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1981; Yancopoulos & Alt 1985). At the IgH locus, for example, µ0 transcripts initiate at 
the DQ52 promoter (Alessandrini & Desiderio 1991), and Iµ transcripts originate within 
the Eµ enhancer (Lennon & Perry 1985; Su & Kadesch 1990). Activation of germline 
transcription at antigen receptor loci is accompanied by alterations in chromatin 
organization and the establishment of chemical modifications characteristic of active 
chromatin, including H3K4me3 (Chakraborty et al. 2007; Goldmit et al. 2005; Liu et al. 
2007; Matthews et al. 2007; Morshead et al. 2003; Subrahmanyam et al. 2012). It is not 
possible to uncouple epigenetic changes from germline transcription, which leaves at 
least three basic hypotheses about the relationship between transcription and epigenetic 
changes: (1) Epigenetic changes at active loci induce transcription; (2) Transcription at 
active loci induces epigenetic changes; or (3) Both epigenetic changes and transcription 
are secondary to another process. Emerging evidence shows that some epigenetic changes 
are important beyond any potential role in facilitating transcription. For example, DNA 
demethylation was observed at junctions at the IgH locus (Selimyan et al. 2013). The 
specificity for junctions may indicate that DNA demethylation marks segments for 
recombination. Similarly, monoallelic Igκ demethylation was observed and proposed to 
be a mechanism of maintaining allelic exclusion (Mostoslavsky et al. 1998). Allelic 
exclusion, or expression of only a single receptor, is critical to maintaining the 
monospecificity of lymphoid cells. There are likely multiple mechanisms that work in 
concert to enforce allelic exclusion. One proposed mechanism is a stochastic mechanism 
based on the observation that most rearrangements are unproductive, therefore 
simultaneous recombination would be unlikely to result in two productive rearrangements 
(Coleclough et al. 1981). After ATM recognizes DSBs in immature lymphocytes, a 
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signaling pathway is initiated to decrease RAG expression (Fisher et al. 2017), decreasing 
the probability of further recombination. Productive rearrangement also signals RAG 
down-regulation. Many mechanisms work in unison to ensure recombination occurs only 
at appropriate loci and that recombination ceases after a single productive rearrangement. 
 
Epigenetic regulation of RAG activity 
The recognition of H3K4me3 by the RAG-2 PHD is not merely a passive 
localization signal. Rather, engagement of H3K4me3 by the PHD finger stimulates 
recombination in vivo (Liu et al. 2007; Matthews et al. 2007) and cleavage of RSS 
substrates in vitro (Shimazaki et al. 2009; Grundy et al. 2010; Lu et al. 2015), conferring 
increases in substrate affinity and catalytic rate (Shimazaki et al. 2009; Lu et al. 2015). 
Affinity for substrate is also increased in the presence of H3K4me3 (Grundy et al. 2010; 
Lu et al. 2015). Evidence suggests that the RAG-2 PHD binds more strongly to 
H3K4me3 peptide with an additional symmetrical dimethylation at arginine 2 
(H3R2me2s) (Ramón-Maiques et al. 2007). Additionally, H3R2me2s can be found in 
vivo and correlates with euchromatin. In pro-B cells, H3R2me2s is positively correlated 
with H3K4me3 across the genome, including the IgH locus (Yuan et al. 2012). Some 
evidence implicates the acidic region between the RAG-2 core and PHD in binding to 
histones. Further, mutations that decreased histone binding ability were associated with 
decreased recombination at endogenous loci (West et al. 2005). Additionally, the C-
terminus of RAG-2 has also been proposed to bind to phosphoinositides (PI). Mutations 
that decreased PI binding also impaired recombination activity. However the W453R 
mutation of the PHD reduced PI binding despite the fact that PI binding was localized 
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outside of the PHD (Elkin et al. 2005). Therefore, H3K4me3 may not be the only 
chromatin feature recognized by the noncore RAG-2. 
 The role of histones in V(D)J recombination does not appear to be limited to 
interactions with histone tails. Nucleosome structures inhibit RAG activity in vitro (Du et 
al. 2008; Golding et al. 1999; Kwon et al. 2000; McBlane & Boyes 2000), ostensibly 
through denying access to the RSS. Nucleosome remodeling with the SWI/SNF ATP-
dependent chromatin remodeling complex alleviated this repression (Du et al. 2008; 
Kwon et al. 2000). Hyperacetylation may bypass this inhibition in some contexts, 
however the data are equivocal. In vitro, hyperacetylation synergized with SWI/SNF 
activity to increase recombination (Kwon et al. 2000) and stimulated recombination 
activity on its own (McBlane & Boyes 2000). However, a report using similar methods 
provided evidence that neither HMGB1 nor hyperacetylation could bypass inhibition by 
nucleosomes (Golding et al. 1999). It is possible that variable results are due to 
differences in experimental conditions, so further work is necessary to elucidate the 
interaction between nucleosomes and acetylation in vitro. In vivo, histone acetylation is 
positively correlated with recombination (McMurry & Krangel 2000), however 
hyperacetylation is generally associated with active enhancers and transcription, both of 
which are intimately tied to V(D)J recombination. An analysis of RAG-1 binding in 
lymphoid cells determined that RAG-1 exhibits two binding modes, one that is explained 
by H3K4me3 and one that is driven by H3K27Ac, primarily in the absence of a 
functional RAG-2 PHD (Maman et al. 2016). The RING domain may mediate this 
interaction, as it has been proposed to bind to histone H3 (Deng et al. 2015; Grazini et al. 
2010; Jones et al. 2011) and the H3K27Ac localization was dependent on noncore RAG-
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1 (Maman et al. 2016). Additionally, polyubiquitination of RAG-1 has been suggested to 
increase recombination frequency. This mode of regulation operates independent of 
H3K4me3 stimulation, as recombination was higher with both H3K4me3 and 
ubiquitination than with either alone (Singh & Gellert 2015). However, RAG-1 isolated 
from human cells is not polyubiquitinated, so further work is necessary to determine 
whether stimulation of RAG activity by autoubiquitination has physiological relevance. 
While this bears further study, these data suggest that there is a role for noncore RAG-1 
in regulation of recombination in vivo. 
 These direct chromatin interactions represent only one type of epigenetic 
regulation of recombination. As V(D)J recombination requires synapsis of gene segments 
over one mega base pair away. CCCTC-binding factor (CTCF) is a zinc-finger protein 
that binds CTCF-binding elements (CBEs) and has been implicated in long range 
chromosome interactions. The IgH locus contains multiple CBEs, the deletion of which 
changes VH usage (Lin et al. 2015). The current model is that DNA looping proteins like 
CTCF function to increase diversity in V(D)J recombination by bringing distal gene 
segments proximal (Choi & Feeney 2014; Medvedovic et al. 2013). These long-range 
interactions are also important in the epigenetic regulation of recombination. 
Given that the V(D)J recombinase DNA-binding domains and catalytic core are 
largely contained within RAG-1 (Kim et al. 2015), the interactions between RAG-2 and 
H3K4me3 are consistent with the interpretation that H3K4me3 is an allosteric activator 
of the V(D)J recombinase. This interpretation was reinforced by the finding that binding 
of H3K4me3 to the RAG-2 PHD finger induces conformational changes in RAG-1 within 
the DNA-binding domains and a domain that acts as a scaffold for the catalytic core 
20 
 
(Bettridge et al. 2017). The point mutation, W453A, impairs recombination more than 
removal of the noncore region. We therefore hypothesized that the PHD inhibits RAG 
activity and the binding of H3K4me3 relieves this inhibition. This model predicts the 
existence of a compensatory mutation in RAG that would render the complex impervious 


















Identification of an inhibitory domain within the noncore region of RAG-2 
 That the deletion of the entire noncore region of RAG-2 would be less detrimental 
than a point mutation in the PHD suggested the presence of an inhibitory domain in 
RAG-2. We reasoned that this domain would be identifiable by second site mutations that 
rescue the activity of RAG-2(W453A). Therefore, we scanned the canonical noncore 
region of RAG-2 with clustered alanine substitutions of nine or ten amino acids each in 
the context of the loss of function RAG-2 W453A mutation. A preliminary screen 
identified two contiguous regions, 388-396 and 397-405, that rescued RAG-2(W453A) in 
an assay for V(D)J recombination (Liu 2009). Therefore, we constructed RAG-2 mutants 
bearing an alanine substitution spanning residues 388 through 405, RAG-2(388-405A18), 
and the same clustered alanine mutation in the context of W453A, RAG-2(388-405A18, 
W453A) (Figure 1A). Recombination activity was impaired in the RAG-2(W453A) 
mutant relative to wild type, as reported previously (Liu et al. 2007). In contrast, the 
double mutant, RAG-2(388-405A18, W453A) was as active as wild-type. Moreover, the 
single mutant, RAG-2(388-405A18) was significantly more active than wild-type (Figure 
1B). Differences in protein accumulation did not account for the differences in 
recombination activity (Figure 1C). The gain of function mutation was consistently 
observed in distinct assays for signal joining (data not shown) and in an assay for coding 
joining (Figure 1D), as well as in combination with a mutation (T490A) that uncouples 
RAG-2 accumulation from the cell cycle (Figure 1E). Additionally, the 388-405A18 
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Figure 1. The RAG-2 noncore region contains an inhibitory domain 
(A) RAG-2 mutants. Above: diagram of RAG-2. Core refers to the canonical core region; 
linker (L), plant homeodomain (PHD), and signal for cell cycle-dependent degradation 
(D) are indicated. Initial and terminal amino acid residues as well as residues bounding 
the core, linker and PHD finger are numbered. Below: amino acid sequences (from 
residue 334 through 456) of wild-type RAG-2 and RAG-2 mutants. Red type indicates 
residues residing in the canonical core region. Hyphens indicate identity to wild-type.  
(B) Rescue of an inactivating PHD finger mutation on signal joints. Recombination (%) 
is a calculation of the frequency of signal joining of the pJH200 signal joint 
recombination substrate (Hesse et al. 1987). Substrate, full-length RAG-1, and the 
indicated RAG-2 variant (vector (V), wild-type RAG-2 (wt), or indicated mutant) were 
transfected into NIH3T3 cells. The bars represent the mean ± SEM, n = 3 independent 
transfections, representing ≥ 500 ampicillin (A)-resistant colonies per RAG-2 variant and 
≥ 200 A-resistant colonies for vector alone. Significant differences were determined by 
ANOVA (***p < 0.001; **p < 0.01).  
(C) Immunodetection of RAG fusion proteins in recombination assays. NIH3T3 cells 
were co-transfected in triplicate with pJH200, RAG-1 and vector (pcDNA1), wild-type 
RAG-2, RAG-2(388/405A18), RAG-2(W453A) or RAG- 2(388/405A18, W453A). An 
aliquot of cells from each transfection was lysed and RAG proteins (upper panel) or actin 
(lower panel) were detected by immunoblotting with an anti-myc or anti-actin antibody, 
respectively. Positions of RAG-1 and RAG-2 fusion proteins are indicated.  
(D) Rescue of an inactivating PHD finger mutation on coding joints. As in (B) performed 
with pJH290, a surrogate for coding joint formation.  
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(E) The RAG-2 388/405A18 mutation stimulates signal joining independent of cell cycle-










Figure 2. Inhibitory domain mutation is not associated with aberrant joining 
(A) Signal joints obtained from extrachromosomal assays with wild-type RAGs. 
Nonamer and heptamer sequences associated with the 12-RSS and 23-RSS are indicated 
in boldface type; the number of independent clones represented by each sequence are 
indicated on the right. Insertions and deletions (dashes) are indicated in red type. 











Initial definition of the inhibitory domain 
 The amino-terminal boundary of the inhibitory domain was defined by extending 
the alanine scanning mutagenesis into the canonical core region of RAG-2 (Figure 1A). 
RAG-2(370/387A18) exhibited a gain-of-function phenotype comparable to that of RAG-
2(388/405A18), whereas RAG-2(352/369A18) supported wild-type levels of 
recombination and RAG-2(334/351A18) was not recombination-competent (Figure 3A). 
Mutations carboxy-terminal to residue 405 failed to confer a gain-of-function phenotype 
(Figure 3A). RAG protein accumulation was comparable between the RAG-
2(370/387A18) and RAG-2(388/405A18) mutations (Figure 3B). 
 
Disruption of inhibition uncouples recombination of endogenous gene segments 
from H3K4me3 recognition 
 We employed a qualitative assay to determine whether disruption of the putative 
RAG-2 inhibitory domain could bypass the dependence of RAG activity on H3K4me3 
recognition (Figure 3C). To do so, we expressed wild-type RAG-2, RAG-2(388/405A18), 
RAG-2(W453A), or RAG-2(388/405A18, W453A) in a RAG-2-deficient pro-B cell line 
using a retroviral vector that confers puromycin resistance. At 25 days of selection, 
DSP2-to-JH joining was assayed (Liu et al. 2007). Rearrangements were detected in cells 
transduced with core RAG-2, wild-type RAG-2, or RAG-2(388/405A18) (Figure 3D, 
lanes 3-5). Rearrangement was profoundly reduced in cells transduced with RAG-
2(W453A) (Figure 3D, lane 6). The debilitating effect of the W453A mutation was 
reversed, however, but the second site mutation of residues 388-405 (Figure 3C, lane 7). 
Consistent with the interpretation that relief of autoinhibition bypasses the dependence of 
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endogenous V(D)J recombination on recognition of H3K4me3 by RAG-2. This result 








































Figure 3. Initial localization of the RAG-2 inhibitory domain 
(A) Mapping of the inhibitory domain. Signal joining (mean ± SEM, n = 3 independent 
biological replicates, representing ≥ 100 A-resistant colonies per RAG-2 variant) was 
assayed using full-length RAG constructs and analyzed by ANOVA, ***p < 0.001; *p < 
0.05. 
(B) Immunoblotting of RAG-2(370/387A18) and wild-type RAG-2 in transfected NIH3T3 
cells. RAG-2 (upper panel) and actin (lower panel) were detected by anti-myc and anti-
actin respectively. 
(C) Representation of a portion of the IgH locus with relative positions of primers and the 
probe used to assay endogenous DSP2-JH joining. 
(D) Rescue of W453A by 388/405A18 in an assay for endogenous rearrangement. Top: 
assay for DSP2-JH joints in genomic DNA from uninfected cells (Un) or cells transduced 
with the following: vector (V), core RAG-2 (C), wild-type full-length RAG-2 (WT), or 
full-length RAG-2 mutants. Positions of the DSP2-JH recombinants are indicated at left. 
Middle: immunodetection of myc-tagged RAG-2 species with an anti-myc antibody. 





The RAG-2 inhibitory domain mutant exhibits increased basal activity, but remains 
responsive to H3K4me3 (in collaboration with Chao Lu) 
 The ability of the 388/405A18 mutation to rescue activity of a PHD finger mutant 
was consistent with (1) disruption of an inhibitory domain whose action in the wild-type 
protein is relieved by H3K4me3 or (2) disruption of a separate mode of autoinhibition 
whose action is independent of H3K4me3 binding. To test these possibilities, we assayed 
wild-type RAG-2, RAG-2(W453A), RAG-2(388/405A18), and RAG-2(388/405A18, 
W453A) (Figure 4A) with c RAG-1ct (Figure 4B) for responsiveness to H3K4me3 in a 
coupled cleavage assay. Equivalent amounts of active tetramer, as determined by burst 
kinetic analysis (Figure 5) were assayed for coupled cleavage of a radiolabeled 12-RSS in 
the presence of increasing concentrations of H3K4me0 or H3K4me3 (Figure C). As 
expected, H3K4me3 stimulated hairpin formation by wild-type RAG: at 4 µM H3K4me3, 
the yield of hairpin product was more than 10-fold greater than in the absence of the 
peptide (Figure 4D, right). Stimulation was specific to H3K4me3, as H3K4me0 had no 
effect on coupled cleavage activity (Figure 4D, left). RAG-2(W453A) exhibited basal 
activity comparable to that of wild-type RAG-2 (Figure 4D, right), indicating that an 
intact PHD finger is required for stimulation. Consistent with its ability to rescue the 
function of RAG-2(W453A) in vivo, the 388/405A18 mutation was associated with 
increased basal cleavage activity, either alone or in combination with W453A (Figure 4D, 
left). Despite this increase in basal activity, RAG-2(388/405A18) could be stimulated by 
H3K4me3 (Figure 4D); responsiveness required an intact PHD finger, as RAG-
2(388/405A18, W453A) was not stimulated (Figure 4D, right). Consistent with these 
observations, RAG-2 fragments bearing the W453A and the 388/405A18, W453A double 
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mutation failed to bind H3K4me3, whereas a fragment bearing the 388/405A18 mutation 
retained the ability to bind (Figure 6A, B). Altogether, these observations indicate that the 
388/405A18 gain-of-function mutation confers increased basal cleavage activity in vitro, 
but this mutation spares one or more additional inhibitory functions that can be relieved 
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Figure 4. Mutation of the RAG-2 inhibitory domain increases coupled cleavage in 
vitro 
(A) Diagrams of RAG-2 constructs. Amino acid residues at domain boundaries are 
numbered. The core is shown in dark gray with Kelch-like domains (KL) indicated. The 
PHD finger (PHD) and degradation signal (D) in the noncore region are indicated. MBP, 
Myc, and His denote the maltose binding protein, c-myc epitope, and polyhistidine tags, 
respectively. 
(B) Diagrams of wild-type RAG-1 (top) and core RAG-1ct-MH (cR1ct-MH, bottom). 
Amino acid residues at domain boundaries are numbered. The core is designated in dark 
gray. The RING-type zinc-finger domain (RING/ZFD) and the nonamer binding domain 
(NBD) are indicated. Arrowheads mark the catalytic residues.  
(C) Coupled cleavage reactions contained radiolabeled 12-RSS, unlabeled 23-RSS, and 
wild-type (WT) RAG-2 or RAG-2 mutants as defined at top. K4me0 and K4me3, 
reactions supplemented with 0.5, 1, 2, or 4 μM H3K4me0 or H3K4me3 peptide; −, 
reactions lacking peptide. Positions of hairpin (HP) and nicked (N) products are indicated 
by arrows. 
(D) Accumulation of hairpin product at 1 hr (nM product) is plotted as a function of the 
concentration of H3K4me0 (left) or H3K4me3 (right). Blue diamonds, wild-type RAG-2; 

























































































































Figure 5. Burst kinetic and surface plasmon resonance analyses of wild-type and 
mutant RAG complexes 
(A) Complexes of cRAG-1ct with full-length wild-type RAG-2 were assayed for nicking 
of a 12-RSS substrate at various nominal RAG concentrations. Upper panels, 
accumulation of nicked product as a function of time; nominal RAG concentration, 
calculated based on tetrameric stoichiometry, is indicated at right. Lower panels, 
estimation of active fraction. The kinetic curves of the upper panels were extrapolated to 
zero time to give the [N]0 associated with each nominal RAG concentration ([RAG 
tetramer]). [N]0 was then plotted as a function of [RAG tetramer]; the slope of each 
resulting curve represents the fraction of active RAG in the preparation.  
(B) RAG-2(W453A) analyzed as in (A). 
(C) RAG-2(388/405A18) analyzed as in (A). 
(D) RAG-2(388/405A18, W453A) analyzed as in (A). The active fractions of the four 
preparations were similar, ranging from 4.6 percent to 6.1 percent. 
(E) Surface plasmon resonance assays for the association of RAG-2PHD(388/405A18) 
and RAG-2PHD(388/405A18, W453A) with a histone H3K4me3 peptide. Biotin-tagged 
H3K4me3 peptide (residues 1 – 21) was immobilized at 24 pmol on biosensor chips. 
GST-tagged RAG-2PHD variants were brought to 2 µM and injected for 10 min at a flow 
rate of 5 μl/min. Subsequently, running buffer alone was injected for 10 min. 






H3K4me3 and inhibitory domain mutation stimulate substrate binding (in 
collaboration with Chao Lu) 
  The stimulatory effect of the 388/405A18 mutation could result from increased 
affinity for substrate, increased catalytic activity, or both. To distinguish these 
possibilities, we assessed substrate binding and catalysis. To measure affinity for DNA 
substrate, a 12-RSS fragment was incubated with increasing concentrations of wild-type 
RAG in the presence of 4 μΜ H3K4me0 or H3K4me3 peptide. Incubation was carried 
out in the presence of Ca2+, which supports the binding of RAG to substrate in the 
absence of DNA cleavage. The fraction of total substrate remaining in the unbound state 
was determined (Figure 6A) and expressed as a function of active RAG concentration 
(Figure 6C), as defined by burst kinetics under the assumption that the active unit is a 
heterotetramer of composition (RAG-1)2(RAG-2)2 (Yu & Lieber 2000). Dissociation 
constants, KD, were determined (see the Materials and Methods). The addition of 
H3K4me3 was accompanied by an increase in the affinity of wild-type RAG for substrate 
DNA, relative to H3K4me0; in contrast, the affinity of RAG-2(388/405A18) for a 12-
RSS substrate was similar in the presence of H3K4me0 or H3K4me3 (Figures 6B and 
3D). We also performed direct comparisons of substrate binding by each RAG species in 
the presence of H3K4me0 (Figure 6E) or H3K4me3 (Figure 6F). In the presence of 
control peptide, the affinities (KD) of RAG-2(388/405A18) and wild-type RAG for 
substrate were estimated at 88 nM and 242 nM, respectively (Figure 6G). In the presence 
of H3K4me3, wild-type RAG and RAG-2(388/405A18) bound substrate with an 
estimated KD of 76 nM and 84 nM, respectively (Figure 6H), similar to the affinity of 
RAG-2(388/405A18) for substrate in the presence of H3K4me0. Thus the 388/405A18 
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mutation confers a constitutive increase in substrate binding affinity by RAG independent 
























































































































































































































































































































































































Figure 6. The RAG-2(388/405A18) mutation stimulates RAG-RSS binding 
(A) Electrophoretic mobility shift assay (EMSA) for binding of wild-type RAG to a 
consensus 12-RSS in the presence of H3K4me0 or H3K4me3 peptide as indicated at top. 
Probe shows 12 RSS incubated in the absence of RAG. The concentration, in μΜ, of 
active RAG in each binding reaction is indicated above the lane. 
(B) EMSA as in (A) except that RAG-2(388/405A18) was substituted for wild-type 
RAG-2. 
(C) H3K4me3 reduces the KD of RAG-RSS binding. The fraction of free probe (fraction 
DNA unbound) in each binding reaction of (A) was plotted as a function of active RAG 
concentration. Data from reactions containing H3K4me0 and H3K4me3 are indicated by 
blue squares and red triangles, respectively. 
(D) The RAG-2 388/405A18 mutation relieves responsiveness of RAG-RSS binding to 
H3K4me3. The fraction of free probe (fraction DNA unbound) in each binding reaction 
of (B) is plotted as in (C). 
(E) EMSA for binding of wild-type RAG (left) or RAG-2(388/405A18) (right) to a 
consensus 12-RSS in the presence of H3K4me0. Probe, 12 RSS incubated in the absence 
of RAG. The concentration of active RAG in each reaction is indicated above the lane. 
(F) EMSA as in (E), except that H3K4me3 was substituted for H3K4me0. 
(G) The RAG-2 388/405A18 mutation increases basal affinity of RAG for RSS in the 
absence of H3K4me3. The fraction of free probe (fraction DNA unbound) in each 
binding reaction of (E) was plotted as a function of active RAG concentration. Data from 
reactions containing RAG-2(388/405A18) and wild-type RAG-2 are indicated by blue 
squares and red triangles, respectively. 
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(H) The fraction of free probe (fraction DNA unbound) in each binding reaction of (F) is 
plotted as in (G). 




H3K4me3 and the 388/405A18 mutation stimulate RAG catalysis (in collaboration 
with Chao Lu) 
 Because the 388/405A18 mutation uncoupled the high affinity state from 
H3K4me3 binding, we could assess the effect of H3K4me3 on kcat in the absence of its 
effect on KD. We assayed nicking of a pre-bound 12-RSS substrate at concentrations 
from 10 nM to 60 nM by RAG-2(388/405A18) in complex with cR1ct-MH. Reactions 
were carried out at an active RAG tetramer concentration of 1.5 nM in the presence of 4 
μM H3K4me0 or H3K4me3 peptide (Figure 7A). Following determination of Vmax 
(Figures 7B and 7C), kcat was estimated (Materials and Methods). In the presence of 
H3K4me0, RAG-2(388/405A18) supported nicking with an apparent kcat of 4.95 min
−1, 
which increased to 7.06 min−1 in the presence of H3K4me3 (Figure 7C, D). In 
comparison, we observed turnover rates of 0.83 min−1 and 3.76 min−1 for wild-type 
RAG-2 in the presence of H3K4me0 or H3K4me3, respectively (Figure 7D), consistent 
with previous estimates (Shimazaki et al. 2009). Thus, the 388/405A18 mutation is 
associated not only with increased affinity for substrate but also with a 6-fold increase in 
the basal kcat for DNA nicking; the basal kcat observed for RAG-2(388/405A18) is similar 
to that observed for wild-type RAG-2 in the presence of H3K4me3. Nonetheless, RAG-
































Vmax = 7.43 nM/min 
kcat = 4.95 min
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 RAG-2 RAG-2(388/405A18) 
 +H3K4me0 +H3K4me3 +H3K4me0 +H3K4me3 
KD 242 nM 76 nM 88 nM 84 nM 




Figure 7. Disruption of the RAG-2 inhibitory domain and H3K4me3 binding both 
stimulate RAG catalysis 
(A) Assay for RSS nicking. Reactions contained 1.5 nM RAG-2(388/405A18) and 12-
RSS substrate HL44/45 at 10, 20, 40, or 60 nM. Reactions were supplemented with 4 μM 
H3K4me0 or H3K4me3 peptide as indicated at top. Accumulation of nicked product 
(arrow) was assayed at times ranging from 0 to 2.5 min. 
(B) Concentration of nicked product as determined in (A) is plotted against time for each 
substrate concentration. Blue, 10 nM; orange, 20 nM; gray, 40 nM; and yellow, 60 nM. 
Left: reactions containing H3K4me0; right: reactions containing H3K4me3. 
(C) Reaction velocity (V) is plotted in nM/min as a function of substrate concentration 
([S]). Vmax was determined by nonlinear regression analysis (Materials and Methods); kcat 
= Vmax/[RAG]T, where [RAG]T is the total concentration of active RAG tetramer. 
(D) Estimates of dissociation constants (KD) and catalytic rate (kcat) for full-length wild-
type RAG-2 and full-length RAG-2(388/405A18) in complex with cR1ct-MH. KD was 
measured for a canonical 12-RSS substrate; kcat was determined in an assay for nicking of 




Characterization of the inhibitory domain within the noncore region of RAG-2 
 The RAG-2 W453A mutation disrupts the PHD finger, abolishes specific binding 
of the recombinase to H3K4me3 and impairs recombination in vivo. Contiguous 
mutations of RAG-2 from amino acid 370 to 405 stimulated the activity of RAG-
2(W453A) (Figure 3A). This interval is predominantly acidic with interspersed proline, 
serine, threonine and phenylalanine residues (Figure 8A). We wished to determine the 
relative contributions of these residues to inhibition of RAG recombination activity. This 
was of particular interest because structural analysis suggested that the RAG-2 PHD 
finger could engage a proline residue in the absence of H3K4me3 (Ramón-Maiques et al. 
2007). Mutation of the proline residues resulted in no difference in recombination activity 
(Figure 8B). Mutation of the serine and threonine or phenylalanine (Figure 8C) residues 
conferred only modest increases in recombination activity. In contrast, neutralization of 
acidic residues in the 370-405 interval RAG-2(D/E370-405A) increased recombination 
activity to the level observed for RAG-2(370-387A18) (Figure 8C). These differences in 































































































































































































Figure 8. Localization of the RAG-2 inhibitory domain to the acidic residues 
spanning amino acid 352 to 405 
(A) Diagram of RAG-2 with the canonical core (CORE) and plant homeodomain (PHD) 
indicated. Amino acids at domain boundaries are numbered. The location of W453 is 
noted with a dotted line. T490 is noted with a solid line. Below: Wild-type RAG-2 
sequence from amino acid 352 through 405 (top) compared with the sequences of RAG-2 
mutants. Mutated residues are indicated in bold type. 
(B) Activity of RAG-2 proline mutations on an extrachromosomal signal joint substrate, 
pJH200. Recombination frequencies from individual transfections are plotted with mean 
± standard deviation (SD). Brown-Forsythe test was used to ensure SDs were not 
significantly different (p > 0.05). One-way ANOVA was used with Tukey’s multiple 
comparison post-test. *** sample was significantly different (p > 0.001) from all other 
samples and was the only significant difference. 
(C) Activity of RAG-2 mutations on an extrachromosomal substrate as in (B). Not all 
significant differences are indicated. * notes that means that were significantly different 
(p > 0.05). 
(D) Top panel: Immunodetection of RAG-2 variants in (B) using an anti-myc antibody. 
Bottom panel: Actin, detected with anti-actin, is used as a loading control. 






The RAG-2 inhibitory domain acts independently of the PHD 
 The predominance of acidic residues extends to residue 352, therefore we asked 
whether inhibition of RAG activity could be further relieved by truncation into this 
region (Figure 9A). Carboxy-terminal truncation of RAG-2 from residue 405 to 351 was 
associated with a significant (p < 0.01) increase in recombination (Figure 9B) activity 
despite decreased protein expression (Figure 9E). Moreover, recombination activity was 
increased when neutralization of acidic residues was extended from residue 370 to 352 
(ns, p = 0.0891) (Figure 9C). Prior work suggested that further neutralization would 
impair recombination activity, as RAG-2(334-351A18) was inactive on an 
extrachromosomal substrate (Figure 3A). In all subsequent experiments to test relief of 
inhibition, we used the optimally active RAG variant, RAG-2(D/E352-405A). 
 Importantly, the stimulatory effects of truncation on recombination suggested that 
the inhibitory domain does not exert its suppressive effects solely through an interaction 
with the PHD finger (Figure 9B). To confirm this, we mutated the inhibitory domain in 
the context of a RAG-2 construct lacking the PHD finger. The resulting mutant, RAG-
2(1-405, D/E352-405A), exhibited a significant increase in function relative to the RAG-
2(1-405) mutant (Figure 9D). None of these differences in activity could be attributed to 



































































































































































































































































Figure 9. The RAG-2 inhibitory domain acts independent of the PHD 
(A) Diagram of the RAG-2 truncations used in this study. Numbers indicate the 
boundaries of defined domains. The canonical core (CORE) is in light gray with the plant 
homeodomain (PHD) in dark gray. The position of W453 is marked with a dashed line 
and the location of T490 is marked with a solid line. D/E in medium gray indicates a 
truncation at 405 combined with the D/E352-405A inhibitory domain mutation. 
(B) The inhibitory domain spanning residues 352 through 405 functions in the absence of 
the PHD. Recombination frequency plotted for three independent transfections of the 
pJH200 extrachromosomal substrate, RAG-1, and the indicated RAG-2 variant. Brown-
Forsythe test was used to ensure SDs were not significantly different (p > 0.05). One-way 
ANOVA was used with Tukey’s multiple comparison post-test. All significant 
differences not shown, ** indicates the means are significantly different (p < 0.01). 
(C) Comparison of RAG-2 inhibitory domain neutralization mutations. Analyzed as in 
(B). Both mutations were significantly higher than wild-type RAG-2 (p < 0.0001), but 
not significantly different from each other (p = 0.0891). 
(D) Neutralization of the interval between 352 and 405 relieves inhibition in the context 
of truncated RAG-2. Analyzed as in (B). All significant differences not shown, * 
indicates means are significantly different (p < 0.05), *** indicates means are 
significantly different (p< 0.001). 
(E), (F), and (G) represent immunodetection of RAG-2 variants for (B), (C), and (D) 
respectively with an anti-myc antibody (top) and actin as a loading control (bottom).  
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The RAG-2 inhibitory domain suppresses recombination in B progenitor cells 
 We asked whether disruption of this inhibitory domain would affect 
rearrangement of endogenous immunoglobulin loci. Our initial experiments employed the 
RAG-2-deficient pro-B cell line, 63-12. Wild-type RAG-2 or RAG-2 mutants were 
introduced by retroviral transduction and both Vκ-to-Jκ (Figure 10A) and DH-to-JH joining 
(Figure 10B) were assayed. In cells transduced with wild-type RAG-2, and not those 
transduced with vector alone, we observed robust Vκ-to-Jκ (Figure 10C top and 10D, 
compare - and wt) and DH-to-JH joining (Figure 10C middle and 10E, compare - and wt). 
The RAG-2 W453A mutation impaired recombination at both loci (Figure 10C-E, 
W453A) and this debilitating effect was reversed by secondary mutation of the inhibitory 
domain (Figure 10C-E, compare W453A and D/E352-405A, W453A). The observed 
effects of mutation on recombination were not explained by differences in expression of 
RAG-2 (Figure 10F).  
We introduced the same RAG-2 constructs into RAG-2-deficient Abelson murine 
leukemia virus (AbMuLV)-transformed B progenitor cells in which cell cycle arrest, 
RAG-1 expression and V(D)J recombination are inducible by treatment with STI-571 
(Gapud et al. 2011). In the absence of STI-571 wild-type RAG-2 and RAG-2(D/E352-
405A) supported a low level of Vκ-to-Jκ (Figure 11A, B, DMSO lanes) and DH-to-JH 
rearrangement (Figure 11C, D, lanes DMSO lanes) and this increased further after 48 
hour treatment with STI-571 (Figure 11A-D, 48hr lanes). Recombination at both loci was 
impaired by the RAG-2 W453A mutation (Figure 11A-D, lanes W453A), and this 
impairment was partially reversed by a second-site mutation in the inhibitory domain 
(Figure 11A-D, lanes D/E352-405A, W453A). The differential effects of these mutations 
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on recombination could not be attributed to differences in expression of RAG-2 protein 
(Figure 12D) or on differences in germline transcription from the IgH µ0 or Iµ promoters 
(Figure 11E, F). 
The R2K3 pre-B cell line carries an integrated recombination reporter that permits 
quantitation of recombination (Figure 12A). After introduction of RAG-2 by retroviral 
transduction and cell cycle arrest with STI-571, inversional joining of recombination 
signal sequences within the reporter reorients the GFP cassette to permit its expression 
from an upstream promoter (Figure 12B). As assayed by flow cytometry for fluorescence, 
no recombination was observed in R2K3 cells lacking RAG-2, either before or after 
induction (Figure 12B, panel no RAG-2 and Figure 12C). Cells transduced with RAG-2 
exhibited a low level of recombination, which increased robustly at 48 and 96 hours after 
induction by STI-571 (Figure 12B, panel RAG-2 and Figure 12C). Recombination was 
nearly abolished by the RAG-2 W453A mutation (Figure 12B, panel RAG-2(W453A) 
and Figure 12C) and this effect was modestly but reproducibly reversed by a second site 
mutation in the inhibitory domain (Figure 12B, panel RAG-2(D/E352-405A, W453A) 
and Figure 12C). Mutation of the inhibitory domain alone conferred a reproducible 
increase in the frequency of recombination relative to wild-type (Figure 12C). These 
differences were not due to differences in protein expression (Figure 12D) or differences 
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Figure 10. The RAG-2 inhibitory domain bypasses the requirement for a functional 
PHD in 63-12 cells 
(A) Diagram of the assay for rearrangement of the Igκ locus. A degenerate primer that 
binds to the seven most commonly used Vk segments was designed (Aoki-Ota et al. 
2012) and used with a primer 5’ of the κ intronic enhancer (MiEκ) (Inlay et al. 2002). 
Variable (V), joining (J), and constant (C) regions are indicated. Jκ3 is a pseudogene not 
used in light chain recombination. After recombination brings the V-primer in proximity 
of the J-primer, the 4 PCR products are visible by gel electrophoresis and southern 
blotting. 
(B) Diagram of the assay for rearrangement of the IgH locus. DSP2 or DFL16.1 primers 
were used with a primer 3’ of JH4 to detect D-to-J joining in the IgH locus. As in (A) for 
the IgH locus. 
(C) The RAG-2 inhibitory domain second-site mutation increases recombination activity 
of RAG-2(W453A) in 63-12 cells. Top: Recombination of the Igκ locus assayed by 
southern blot, numbers 1 through 4 mark the location of PCR products for the four 
functional J segments. Middle: Southern blot of endogenous DH-to-JH recombination at 
the IgH locus with the numbers 1 through 4 indicating the positions of products formed 
with the four functional J segments. Bottom: Ethidium bromide-stained gel showing a 
PCR of the RAG-1 locus to control for DNA quality. 
(D) Quantification of the southern blot for Igκ rearrangement. 
(E) Quantification of the southern blot for IgH rearrangement. 
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Figure 11. The RAG-2 inhibitory domain bypasses the requirement for a functional 
PHD in R2K3 cells 
(A) Igκ recombination in R2K3 cells. R2K3 cells stably expressing empty vector (-), 
wild-type RAG-2 (wt), or the indicated RAG-2 mutation were arrested with STI-571 for 
48 hours (control cells were treated with the same volume of DMSO). Recombination of 
the Igκ locus was assayed by southern blot as described Figure 10. 
(B) Quantification of recombination at the Igκ locus. 
(C) IgH recombination in R2K3 cells. Top: R2K3 cells were treated as in (A) and 
recombination of the IgH locus was assayed by southern blot as in Figure 10. Bottom: 
PCR of RAG1 visualized by ethidium bromide as a control for DNA quality. 
(D) Quantification of recombination at the IgH locus. 
(E) Diagram of the IgH locus with the assayed germline transcripts noted. The µ0 
transcript is initiated at a promoter 5’ of DQ52, the most 3’ D-segment. The PCR product 
detected for this transcript is noted as a line 3’ of DQ52. Multiple Iµ transcripts originate 
from the Eµ enhancer 3’ of the J-segments in the direction of the constant (Cµ) region. 
The approximate location of the PCR product is shown with a line. 
(F) Assay for germline transcription at the IgH locus. RNA was isolated from 
independent R2K3 samples arrested with STI-571 for 48 hours. cDNA was generated 
with (+) and without (-) reverse-transcriptase (RT) and a PCR was performed for Iµ (top 
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Figure 12. The RAG-2 inhibitory domain suppresses recombination on an 
integrated substrate in R2K3 cells 
(A) Diagram of the integrated substrate, PMX-INV (Gapud et al. 2011). An inverted GFP 
cassette is flanked by two RSSs (triangles) in the context of genomic sequence 
(represented as squares). After arrest with STI-571 induces arrest, RAG cleaves at the 
RSS heptamer and the reporter is inverted and joined so that GFP is constitutively 
expressed. 
(B) Representative flow cytometry plots of GFP expression of the indicated RAG variant 
arrested with STI-571 for 96 hours.  
(C) Quantification of flow cytometry for GFP expression for three independent infections 
(mean ± SD). Bars give the percentage of cells GFP positive in control treated (DMSO) 
cells and cells arrested with STI-571 for 48 or 96 hours. 
(D) Immunodetection of the myc-tagged RAG-2 variants transduced in R2K3 cells with 





The RAG-2 inhibitory domain acts prior to repair 
In the experiments described above we defined an inhibitory domain in RAG-2, 
the disruption of which stimulated V(D)J recombination within extrachromosomal and 
integrated substrates as well as at endogenous loci. RAG participates in all stages of 
V(D)J recombination from binding to synapsis and cleavage to repair. RAG-induced 
breaks are repaired in collaboration with components of the NHEJ machinery. We asked 
whether the suppressive effect of the inhibitory domain was exerted during repair. To do 
so, we employed cell lines deficient in the NHEJ factors XRCC4 or DNA-PKCS. Should 
the inhibitory domain function through an interaction with the NHEJ machinery, then in 
the absence of NHEJ we would expect inactivation of the inhibitory domain to fail to 
stimulate recombination. In extrachromosomal assays for signal joint (Figure 13A) and 
coding joint (Figure 13B) formation the D/E352-405A mutation reversed the effect of the 
W453A mutation to a similar extent in NHEJ-proficient and NHEJ-deficient cell lines. 
Moreover, RAG-2(D/E352-405A) exhibited a robust gain-of-function, compared to wild-
type in all three cell lines (Figure 13A, B). The effects of these mutations were not 
attributable to differences in protein expression (Figure 13C). Prior work suggested that 
mutation of acidic residues within this region increases the usage of alternative NHEJ 
(alt-NHEJ) (Coussens et al. 2013), which is characterized by excessive deletions and 
microhomology (Deriano & Roth 2013). The use of microhomology is not, however, 
restricted to alt-NHEJ (Pannunzio, Li, Watanabe, & Lieber, 2014). In wild-type cells, all 
but one of the recovered signal junctions produced by RAG-2 variants were precise 
(Figure 14), suggesting that the robust increase in recombination frequency associated 
with the D/E352-405 mutation does not result from the use of alt-NHEJ. In wild-type 
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cells, similar use of microhomology and deletion at coding joints were observed for all 
RAG-2 variants assayed (Figure 16E, F). While we could obtain few junctions in assays 
of wild-type RAG-2 in repair-deficient cell lines, the signal junctions obtained from cells 
expressing the RAG-2 inhibitory domain mutants were characterized by an increase in 
excessive deletion that was not accompanied by an increased use of microhomology 
(Figure 16A-D). Moreover, the relative increase in recombination activity conferred by 
disruption of the RAG-2 inhibitory domain is similar regardless of deficiencies in NHEJ. 
These data are therefore consistent with an increase in the activity of RAG-2(D/E352-
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Figure 13. The inhibitory domain suppresses recombination in the absence of 
classical non-homologous end joining 
(A) Signal joining of RAG-2 inhibitory domain mutants in NHEJ-deficient cells. 
Extrachromosomal signal joining was assayed in wild-type Chinese hamster ovary 
(CHO) cells as well as derivatives deficient for XRCC4 and DNA-PKCS. Signal joint 
recombination of each RAG-2 mutant was determined in three independent transfections 
in each of the three cell lines. Recombination frequency for each cell line was normalized 
to wild-type RAG-2 (wt). Plotted as normalized mean ± SD. 
(B) Coding joining of RAG-2 inhibitory domain mutants in NHEJ-deficient cells. 
Assayed as in (A) with the pJH290, coding joint, substrate. 
(C) Immunodetection of RAG-1 and RAG-2 in CHO cells. Top: anti-myc detection of 









Plasmid TGTTTTTGTTCCAGTCTGTAGCACTGTG CAGGTCTC CTGAACCTG CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
Wild-type cells 
wt (4/4) TGTTTTTGTTCCAGTCTGTAGCACTGTG    CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N (5/5) TGTTTTTGTTCCAGTCTGTAGCACTGTG    CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM (5/6) TGTTTTTGTTCCAGTCTGTAGCACTGTG    CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 




352N (5/10) TGTTTTTGTTCCAGTCTGTAGCACTGTG    CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCAC----    ---AGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N   TGTTTTTGTTCCAGTCTGTAGCAC----    ---AGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N   TGTTTTTGTTCCAGTCTGTAGCA-----    ----GTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N   TGTTTTTGTTCCAGTCTGTAGCACTGT-    ----------------------CTGGCTGTACAAAAACC 
352N   TGTTTTTGTTCCAGTCTG---------- A    ---------AGTACTCCACTGTCTGGCTGTACAAAAACC 
DM (2/5) TGTTTTTGTTCCAGTCTGTAGCACTGTG    CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCCAGTCTGTAGCAC----    ---AGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCCAGTCTGTAGCACTGT-    ------------------------------ACAAAAACC 
DM  -125bp (entire RSS deleted) 
XRCC4-deficient cells 
352N  TGTTTTTGTTCCAGTCTGTAGCACTGTG    ----GTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCACTGTG    -------GTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCAC----    ---AGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCNGTCTGTAG-------    -----------TACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGC------    -------------CTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCT-----------    ---------------CCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCACT---    ---------------CCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCAC---- T   ----GTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCACTGTG CTT   ---AGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
352N  TGTTTTTGTTCCAGTCTGTAGCACTG--   CTGAACCTG CACAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCC----------------    --CAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCC----------------    --CAGTGGTAGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCCAGTCTGTAGCACTGT-    ---------AGTACTCCACTGTCTGGCTGTACAAAAACC 
DM  TGTTTTTGTTCCAGTCTGTAC-------    --------------------------------AAAAACC 
DM  -12bp        ------------------CTGTCTGGCTGTACAAAAACC 
DM  -12bp        --------------------GTCTGGCTGTACAAAAACC 
DM  TG-------------------------- (24bp untemplated)        -1 
DM  -300+bp (entire RSS deleted) 
DM  -300+bp (entire RSS deleted) 
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Figure 14. Signal joints from wild-type and NHEJ-deficient cells 
Signal joints obtained from extrachromosomal assays with wild-type RAG-2 (wt), RAG-
2(D/E352-405A) (352N), and the double mutant (DM), RAG-2(D/E352-405A, W453A) 
in wild-type, DNA-PKCS-deficient, and XRCC4-deficient cells. The sequence of the 
plasmid is shown at the top with the heptamers indicated in blue and a portion of the 
intervening sequence shown. Signal joining is typically precise, with the flush heptamer 
of the 12-RSS joining to the flush heptamer of the 23-RSS. Due to the inability to rule out 
clonal expansion during bacterial transformation, only unique sequences from each 
individual transformation are counted. Each section lists the sequences of junctions from 
the given cell line, with the RAG variant that produced each junction on the left. 
Numbers in parentheses note the number of flush signal joints obtained out of the total 
number of unique joints. Bold typeface indicates microhomology and dashes represent 
deletions. The 24bp untemplated addition does not match any sequence in the plasmid or 
genome. The green type shows the templated insertion from the plasmid sequence 














Plasmid GCTGCAGGTCGAC   GGATCCCCGGGGATC 
Wild-type cells 
wt  GCTGCAGGTCGAC   GGATCCCCGGGGATC 
wt  GCTGCAGGTCGAC GT   -----CCCGGGGATC 
wt  GCTGCAGGTCGAC G   ---TCCCCGGGGATC 
wt  GCTGCAGGTCGAC   -GATCCCCGGGGATC 
wt  GCTGCAGGTCGA-   ---TCCCCGGGGATC 
wt  GCTGCAGGTCGA-   ---TCCCCGGGGATC 
wt  GCTGCAGGTCGAC   ----CCCCGGGGATC 
wt  GCTGCAGGTCGAC   -----CCCGGGGATC 
wt  GCTGCAGGTC---   -------CGGGGATC 
W453A  GCTGCAGGTCGAC GT   -GATCCCCGGGGATC 
W453A  GCTGCAGGTCGAC GT   -----CCCGGGGATC 
W453A  GCTGCAGGTCGAC G   ---TCCCCGGGGATC 
W453A  GCTGCAGGTCGAC    -GATCCCCGGGGATC 
W453A  GCTGCAGGTCGA-   ---TCCCCGGGGATC 
W453A  GCTGCAGGTCGA-   ---TCCCCGGGGATC 
W453A  GCTGCAGGTCGAC   -----CCCGGGGATC 
W453A  GCTGCAGGTC---   ------CCGGGGATC 
352N  GCTGCAGGTCGAC GAC   GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GT   -----CCCGGGGATC  
352N  GCTGCAGG----- AT   -----CCCGGGGATC 
352N  GCTGCA------- T   -----CCCGGGGATC  
352N  GCTGCAGGT----   GGATCCCCGGGGATC 
352N  GCTGCAGG-----   --ATCCCCGGGGATC 
352N  GCTGCAGGTCGA-   ---TCCCCGGGGATC 
352N  GCTGCAGGTCGAC   ----CCCCGGGGATC 
352N  GCTGCAGGTCG--   -------CGGGGATC 
352N  GCTGCAGGTC---   -------CGGGGATC 
DM  GCTGCAGGT---- GAT   -----CCCGGGGATC 
DM  GCTGCAGGTCGAC GT   -----CCCGGGGATC 
DM  GCTGCAGGTCGA- T   -----CCCGGGGATC 
DM  GCTGCAGGTCGAC   -GATCCCCGGGGATC 
DM  GCTGCAGGTCGAC   -GATCCCCGGGGATC  
DM  GCTGCAGGCCG--   -GATCCCCGGGGATC 
DM  GCTGCAGGTCGAC   -----CCCGGGGATC 
DM  GCTGCAGGTC---   ------CCGGGGATC 
DM  GCTGCAGG-----   ------------ATC 
DNA-PKcs-deficient cells 
wt   CTGCAGGTCGAC GTCGACTGGATCC  GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTCGATCC    GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTC        -GATCCCCGACGGATC 
352N   TGCAGGTCGAC GTC     ----CCCCGGGGATC 
DM  GCTGCAGGTCGAC GT          -22 
XRCC4-deficient cells 
wt   TGCAGGTCGAC GTC      -GATCCCCGGGGATC 
352N  GCTGCAGGT----     -GATCCCCGGGGATC 
352N  GCTGCAGGTC---     ------CCGGGGATC 
352N  GCTGCAGGTCGAC GTCC    GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTCC    GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTC     GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTC     -GATCCCCGGGGATC 
352N  GCTGCAGGTCGA- TCC     GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTCGATCC    GGATCCCCGGGGATC 
352N  GCTGCAGGTCGAC GTCGATCC     GGATCCCCGGGGATC 
352N  GCTGCA------- CTA       -19 
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Figure 15. Coding joints from wild-type and NHEJ-deficient cells 
Coding joints obtained from extrachromosomal assays with wild-type RAG-2 (wt), RAG-
2(D/E352-405A) (352N), and the double mutant (DM), RAG-2(D/E352-405A, W453A) 
in wild-type, DNA-PKCS-deficient, and XRCC4-deficient cells. The plasmid sequence 
flanking the RSSs is shown at the top. RAG cleavage results in coding hairpins that are 
opened by the Artemis endonuclease after DNA-PKCS phosphorylation. As in Figure 14, 
only unique sequences from each transformation reaction are counted. Sequences of 
complex translocations were obtained, but could not be succinctly described. These were 
included in the analyses of microhomology and deletions, but excluded from this figure. 
Bold typeface indicates microhomology and dashes represent deletions. Palindromic 
insertions, formed from Artemis opening the hairpin with a single strand nick, are 
underlined with potential microhomology in the palindromic sequences marked with a 



































































































































































































































































































Figure 16. Analysis of junctions sequenced junctions from NHEJ-deficient and 
control cells 
(A) Distribution of the length of deletions in signal junctions from XRCC4-deficient 
cells. Presented mean ± SD. Kruskal-Wallis test was performed, ** indicates p < 0.005. 
(B) Lengths of microhomology in signal junctions from XRCC4-deficient cells. 
Analyzed as in (A), ns indicates p > 0.05. 
(C) Distribution of the length of deletions in signal joints from DNA-PKCS-deficient cells 
analyzed as in (A), ns indicates p > 0.05. 
(D) Lengths of microhomology of deletions in signal joints from DNA-PKCS-deficient 
cells analyzed as in (A), ns indicates p > 0.05. 
(E) Distribution of the length of deletions and (F) microhomology in coding junctions 
from wild-type cells. For both, a Kruskal-Wallis test showed the means were not 




The RAG-2 inhibitory domain gates access to chromatin (in collaboration with Gita 
Kumari and Ranjan Sen) 
 The distribution of RAG-2 over chromatin is positively correlated with the 
density of H3K4me3, both within and outside of antigen receptor loci (Ji et al. 2010). 
While recognition of H3K4me3 by RAG-2 is essential for efficient V(D)J recombination 
in vivo ((Liu et al. 2007) and Figures 3, 10, and 11), this requirement can be bypassed by 
inactivation of the inhibitory domain (Figures 3, 10, and 11). These observations, 
together with the robust stimulatory effect that disruption of the inactivating domain 
exerts on recombination, suggested that the RAG-2 inhibitory domain might function in 
modulating access of RAG to chromatin. To test this, we used chromatin 
immunoprecipitation (ChIP) to probe the distribution of RAG-2 and RAG-1 over 
immunoglobulin loci in 63-12 or R2K3 B-progenitor cells expressing wild-type RAG-2 
or RAG-2 mutants.  
In 63-12 cells, wild-type RAG-2 is detected at IgH, where it is localized primarily 
to DQ52 and the JH cluster (Figure 17A), as well as over actively transcribed non-Ig loci 
(Figure 17A and Figure 18C, wt), consistent with previous observations (Ji et al. 2010). 
The RAG-2 W453A mutation, which abolishes binding to H3K4me3 (Liu et al. 2007), 
eliminates association of RAG-2(W453A) with the IgH locus and other active loci 
(Figure 17A and Figure 18C, W453A). Strikingly, disruption of the inhibitory domain in 
the context of the W453A mutation allows RAG-2(D/E352-405A, W453A) to access the 
IgH locus in the absence of H3K4me3 binding (Figure 17A, D/E352-405A, W453A), 
without regaining the ability to bind to adventitious sites (Figure 18C, D/E352-405A, 
W453A). This is consistent with the interpretation that off-target binding of RAG-2 to 
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chromatin is mediated principally if not wholly by H3K4me3. In 63-12 cells expressing 
wild-type RAG-2, RAG-1 is associated with IgH at DQ52 and the JH cluster but unlike 
RAG-2, RAG-1 is not found at the ɣ-actin locus (Figure 17B, wt). Mutation of the RAG-
2 PHD finger greatly reduces the binding of RAG-1 to the IgH locus, suggesting that this 
association is established or maintained by the interaction of H3K4me3 with RAG-2 
(Figure 17B, W453A). Introduction of a second-site mutation in the RAG-2 inhibitory 
domain reverses the effect of the W453A mutation, allowing RAG-1 to bind the IgH 
locus in the absence of an interaction between RAG-2 and H3K4me3 (Figure 17B, 388-
405A18, W453A).  
Similar patterns of RAG-2 and RAG-1 association with the IgH locus and of 
RAG-2 with active non-Ig loci were observed in R2K3 cells expressing wild-type RAG-2 
(Figure 17C, D and Figure 18B, wt) and these patterns were unaffected by mutation of 
the inhibitory domain alone (Figure 17C, D and Figure 18B, D/E352-405A). This binding 
pattern correlated with H3K4me3 deposits at the IgH locus and did not differ between 
mutants (Figure 18A). As was observed for 63-12 cells, the RAG-2 W453A mutation 
greatly reduced binding of RAG-2(W453A) and RAG-1 to all regions of chromatin 
examined (Figure 17C, D and Figure 18B, W453A), while a second mutation in the 
RAG-2 inhibitory domain restored association of RAG-2(D/E352-405A, W453A) and 
RAG-1 with the IgH locus (Figure 17C, D and Figure 18B, D/E352-405A, W453A). 
RAG-2 and RAG-1 were associated with the Jκ cluster of the Igκ locus in R2K3 cells 
expressing wild-type RAG-2 (Figure 17E, F). While the W453A mutation reduced 
binding of RAG-2 to the Igκ locus (Figure 17E, W453A), the reduction was not as great 
as observed at the IgH locus; moreover, disruption of the inhibitory domain did not 
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reverse the effect of the W453A mutation on RAG-2 binding at the Igκ locus (Figure 
17E, D/E352-405A, W453A). Association of RAG-1 with the Jκ cluster was unimpaired 
by the RAG-2 W453A mutation (Figure 17F, W453A), suggesting that the binding of 
RAG-1 to the Igκ locus is independent of H3K4me3 engagement by RAG-2. Taken 
together these observations indicate that the binding of RAG-1 and RAG-2 to the IgH 
locus is dependent, directly or indirectly, on engagement of H3K4me3 by the RAG-2 
PHD finger, and that this requirement is imposed by the RAG-2 inhibitory domain. 
Disruption of the inhibitory domain allows RAG-2 and RAG-1 to access the IgH locus in 
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Figure 17. The RAG-2 inhibitory domain regulates access to the IgH locus 
(A) Chromatin immunoprecipitation (ChIP) of RAG-2 and (B) RAG-1 at the IgH locus in 
63-12 cells expressing wild-type (wt) RAG-2 or the indicated variant. Enrichment of 
RAG was assayed by qPCR at the indicated regions as described (Ji et al. 2010). The 
constant region, Cɣ3 served as a negative control, while ɣ-actin served as a positive 
control for RAG-2, which binds promiscuously to H3K4me3 sites (Liu et al. 2007). Bars 
represent mean ± SD, n=2. 
(C) ChIP of RAG-2 and (D) RAG-1 at the IgH locus in R2K3 cells expressing wild-type 
(wt) RAG-2 or the indicated variant as in (A). 
(E) ChIP of RAG-2 (E) and RAG-1 (F) at the Igκ locus in R2K3 cells expressing wild-
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Figure 18. RAG-2 with an intact PHD binds to sites of H3K4me3 
(A) ChIP detection of H3K4me3 at the IgH locus in R2K3 cells. Enrichment of 
H3K4me3 was assayed by qPCR at the indicated regions as in Figure 17. The actively 
transcribed gene, ɣ-actin served as a positive control, Bars represent mean ± SD, n=2. 
(B) ChIP detection of RAG-2 binding to adventitious H3K4me3-dense sites in R2K3 and 



















 Our observations support a model in which the responsiveness of RAG to 
epigenetic stimulation is conferred by a PHD-mediated inhibitory domain (PID) whose 
action is relieved upon binding of H3K4me3. The ability of exogenous H3K4me3 to 
stimulate the coupled cleavage activity of wild-type RAG was dependent, as expected, on 
binding of H3K4me3 to the PHD finger of RAG-2. H3K4me3 binding exerts at least two 
effects that contribute to enhanced RSS cleavage activity in vitro: increased affinity for 
substrate and faster catalysis. The accessibility of antigen receptor loci to RAG is 
associated with epigenetic modifications characteristic of active chromatin, such as 
H3K4me3, whose recognition by RAG-2 promotes V(D)J recombination. The ability of 
H3K4me3 to stimulate purified RAG cleavage in vitro suggests that H3K4me3 relieves 
inhibition exerted by some feature of the RAG complex. While core RAG-2 supports 
V(D)J recombination in vitro and in vivo in the absence of a PHD, RAG-2 bearing the 
point mutation W453A supports recombination in vitro and exhibits defects in 
recombination in vivo. This suggests that H3K4me3 is not minimally required for 
recombination, it is a requirement that is imposed by noncore RAG-2. Our results are 
consistent with a model in which this PID maintains RAG in a state of low affinity for 
RSSs until allosteric activation through the deposition of H3K4me3.  
We initially identified an acidic inhibitory domain (AcID) whose mutation could 
bypass the impairment imposed by inactivation of the PHD. Disruption of this inhibitory 
region uncouples V(D)J recombination from the requirement for H3K4me3 binding by 
RAG-2. Interestingly, mutation of the AcID mimics the binding of H3K4me3 by 
increasing the affinity of RAG for substrate and enhancing its catalytic rate. While RAG-
2(388/405A18) supports a basal affinity for substrate that is also similar to the maximal 
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induced affinity of wild-type RAG, H3K4me3 induces no further increase in affinity. 
Affinity for substrate was nominally equal between wild type RAG-2 with H3K4me3 and 
the mutant RAG-2(388/405A18) both with H3K4me0 and H3K4me3. We imagine several 
possible reasons that the affinity for substrate of the 388/405A18 cannot be stimulated by 
H3K4me3. It is possible that the observed KD represents the maximum binding 
capabilities of the RAG complex. The observed KD could also represent the maximum 
affinity that can be detected by the assay. Third, it is possible that the inhibitory domain 
relieved by H3K4me3 and the AcID increase affinity for substrate through the same 
mechanism, thus they have the same effect on KD. The basal catalytic rate supported by 
RAG-2(388/405A18) is similar to the maximally induced rate observed for wild-type 
RAG, but is further increased in response to H3K4me3. Thus, the effects of H3K4me3 on 
substrate affinity and catalysis are separable. While the AcID mutation rescued activity of 
the RAG-2(W453A) mutant in vivo, and mimicked binding of H3K4me3 in vitro, 
subsequent study showed that it represents a separate domain that functions, at least in 
part, independent of the PHD.  
The boundaries of the AcID lie within an acidic region of RAG-2, comprising 
residues 352-405. Neutralization of charge in this interval is associated with aberrant 
repair of RAG-mediated DSBs, decreased stability of RAG-signal end complexes, and 
genomic instability (Coussens et al. 2013). While these effects appear to reflect events 
occurring after RSS recognition and DNA cleavage, they may be explained in part by our 
results. An increase in genomic instability, for example, would be consistent with the 
H3K4me3-independent binding we observe upon mutation of the AcID. A unifying 
hypothesis would suggest that the destabilization of signal end complexes and relaxation 
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of repair pathway choice are consequences of the structural alterations that uncouple 
RAG activity from H3K4me3 binding upon mutation of the AcID. For example, if 
formation of a stable signal end complex were to require disengagement of RAG from 
H3K4me3, then mutations that mimic the effect of H3K4me3 engagement, such as those 
identified herein, could compromise signal end complex stability and appropriate repair 
of DNA ends. 
Available data do not provide structural insights into either of these modes of 
inhibition. Recently, the crystal structure of RAG-2 core, from residue 1 to 387, was 
solved. However, there was no density detected for the region from 352 to 387. This is 
consistent with our boundary for the AcID, however it suggests that the inhibition 
exhibited in the truncation mutants is not caused by a protein-protein interaction that 
would have stabilized the AcID. Similarly, because the crystal structure of the RAG-2 
PHD and core were solved separately, there is no structure that provides information 
about how the signal may be propagated. To address this, pulse alkylation mass 
spectrometry was used to determine which cysteines were exposed on the RAG complex 
in the presence of H3K4me3 or H3K4me0 (Bettridge et al. 2017). Robust allosteric 
changes in RAG-1 were observed in complexes in which H3K4me3 is bound to RAG-2. 
Specifically, there were reproducible changes in the DDBD of RAG-1 that may explain 
the increased affinity for substrate observed in wild-type RAG-2 in the presence of 
H3K4me3. Our results are consistent with a model in which a PID maintains RAG in a 
state of low affinity for RSSs until nearby transcriptional activation promotes allosteric 
activation through the deposition of H3K4me3. Due to the similarity of the observed KDs 
for protein complexes relieved of PID- or AcID-mediated inhibition, it is possible that 
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both inhibitory domains induce a conformational change in the DDBD. Further structural 
and pulse-alkylation experiments could provide insight into how these inhibitory domains 
function and how the inhibition imposed by the AcID is relieved.  
Deletions longer than 100 bp were only formed in the presence of the RAG-2 
double mutant, not in the presence of the single AcID mutant. Therefore, it is possible 
that the recognition of H3K4me3 contributes to fidelity of repair through a yet unknown 
mechanism. There is evidence that noncore RAG-2 contributes to repair of RAG-
mediated breaks. Mutation of the acidic residues to alanines conferred a large gain of 
function to wild-type RAG-2. While these mutations neutralized the charge of these 
residues, they also decreased the steric constraints by decreasing the size of the side 
chains. Future work might test whether the neutralization of the aspartic acid and 
glutamic acid side chains in the AcID with asparagine and glutamine, respectively, results 
in the same relief of inhibition as neutralization with alanine. Recombination frequency 
was observed to decrease upon a much smaller replacement mutant of this type (Silver et 
al. 1993). 
Our results are consistent with the possibility that the AcID exerts its suppressive 
effect through interactions with one or more regions of RAG distinct from the PHD 
finger. Due to the relief of inhibition of the RAG-2(W453A) construct through a second 
site AcID mutation, it is plausible that AcID mutation acts through a general increase of 
activity that is independent of the PHD. Mutation of the acidic inhibitory domain 
additionally confers the ability to bypass H3K4me3-dependent localization of RAG-2. 
The RAG-2 AcID appears to govern interactions with chromatin, as it allows correct 
localization of the RAG-2(W453A) mutant that is otherwise not capable of localization at 
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the IgH or Igκ loci. As RAG-2(W453A) behaves like wild-type RAG-2 in vitro, the 
inability to localize correctly in vivo likely contributes to the impairment on endogenous 
loci. The mechanisms that govern locus accessibility during V(D)J recombination have 
not been fully elucidated. Sterile germline transcription precedes recombination (Bolland 
et al. 2007) and is associated with establishment of a permissive chromatin state. Changes 
in the patterns of both H3K4me3 (Ji et al. 2010) and H3K27Ac (McMurry & Krangel 
2000) are observed during development. The pattern of RAG-2 binding follows that of 
H3K4me3 (Ji et al. 2010), while RAG-1 appears to have one mode of binding governed 
by H3K4me3 and one that correlates with H3K27Ac (Maman et al. 2016). The H3K4me3 
binding may be stronger in the presence of H3R2me2s (Ramón-Maiques et al. 2007). 
Further, DNA demethylation has been observed in a monoallelic distribution 
(Mostoslavsky et al. 1998) and specifically at the junctions of recombined alleles 
(Selimyan et al. 2013). Moreover, the initial reports of histone binding activity identified 
regions of the AcID important for histone binding, so this domain might function through 
binding to H3R2me2s, H3K27Ac, or a yet unidentified feature of RAG-accessible 
chromatin. 
We now provide evidence that this acidic inhibitory domain (AcID) in RAG-2 
gates access to chromatin in a manner independent from recognition of H3K4me3. When 
inhibition was relieved by the 388/405A18 mutation, basal cleavage activity in the 
absence of H3K4me3 was similar to that observed for wild-type RAG in the presence of 
saturating H3K4me3 peptide. Similarly, the 388/405A18 mutant exhibited the ability to 
bypass the requirement for H3K4me3 in vivo for localization of RAG-2 to IgH and Igκ 
and for localization of RAG-1 to IgH. The ability of RAG-1 to localize to all antigen 
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receptor loci aside from the IgH locus in the absence of RAG-2 may explain why Omenn 
syndrome patients can create T-cells, but have an almost complete block in B-cell 
development. 
Mutation of AcID results in a robust gain of function in vitro and on 
extrachromosomal substrates. However, there is only a mild increase at endogenous loci 
and the integrated substrate data were equivocal. Similarly, the AcID mutation increased 
activity of RAG-2(W453A) to wild-type levels, or above, on extrachromosomal 
substrates, but recovered relatively less on recombination at the endogenous loci and on 
the integrated substrate. Previous work established that the extrachromosomal substrate is 
associated with H3K4me3 (Liu et al. 2007), so this difference suggests that a feature of 
endogenous loci is less permissive to this inhibitory domain mutant. Conversely, the 
extrachromosomal substrate may be more permissive than endogenous chromatin to 
recombination. This difference may reflect one or more of the still elusive additional 












Supplement: Biochemical studies of the acidic 





Purification of active RAG tetramers 
 Our initial biochemical characterization of the RAG-2(388/405A18) mutation was 
conducted in the presence of both the intact and inoperative PHD. Given our observations 
that the acidic inhibitory domain (AcID) functions independent of the PHD in vivo 
(Figure 9), we sought to extend these findings in vitro. To this end, we purified 
complexes of cRAG-1ct with truncated RAG-2 bearing an intact or neutralized AcID, 
RAG-2(1-405) and RAG-2(1-405, D/E352-305A) respectively. Both proteins eluted 
primarily in fraction 2 and the characteristic shift to lower apparent molecular weight 
seen in all neutralization mutants was evident (Figure S1A). We performed burst kinetics 
of pre-bound complexes at increasing nominal RAG concentrations over time (Figure 
S2). Interestingly, reactions containing the highest concentration of RAG bearing the 
AcID mutation was associated with hairpin product formation despite the omission of 23-
RSS from these reactions (Figure S2A, 120 nM). The calculated active fractions of 11% 
for RAG-2(1-405) and 18% for RAG-2(1-405, D/E352-305A) were higher than 
previously observed (Figure 5). The curve slope is dictated largely by the highest points, 















Supplemental Figure 1. Purification and normalization of activity of RAG 
truncations 
Complexes of cRAG-1ctMH (cR1ct-MH) with RAG-2(1-405) or RAG-2(1-405, D/E352-
405A) were purified by sonication and amylose affinity chromatography. Aliquots of 
each preparation were fractionated by SDS-PAGE alongside a dilution series of bovine 
serum albumin (BSA). Wash shows the wash of the amylose column; F1-F3 designate 
sequential amylose elution fractions. The positions of the RAG-1 and RAG-2 fusion 
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Supplementary Figure 2. Burst kinetic determination of protein active fractions 
(A) The indicated RAG-2 variant, copurified with cRAG-1ct, were assayed for nicking of 
a 12-RSS substrate at various nominal RAG concentrations. Reactions containing the 
indicated nominal RAG concentrations calculated on the basis of tetrameric 
stoichiometry were incubated for the indicated time. Uncut substrate shows the position 
of the substrate in the absence of RAG. The location of the Nicked product is indicated 
and Hairpin? Is used to point out a secondary product that roughly corresponds to the 
position of a hairpin product that should not have been formed in this assay. Product 
calculated by densitometry. 
 (B) Accumulation of nicked product as a function of time graphed from the image in 
(A). Graph of hairpin product (nM) accumulation over time at 30, 60, and 120 nM 
cRAG-1ct/RAG-2(1-405). Linear regression analysis was used to calculate nM product at 
the zero time point (t0), with the given correlation coefficient (R
2). 
(C) Estimation of active fraction of cRAG-1ct/RAG-2(1-405) complexes. The kinetic 
curves in (B) were extrapolated to zero time to give the [N]0 associated with each 
nominal RAG concentration. [N]0 was then plotted as a function of nominal RAG 
concentration; the slope of each resulting curve represents the fraction of active RAG in 
the preparation.  
(D) Quantification of cRAG-1ct/RAG-2(1-405, D/E352-405A) as in (B). 
(E) Graph of initial product formation at a given protein concentration for complexes of 





Biochemical analyses of acidic inhibitory domain mutation in the context of 
truncated RAG-2 
 Coupled cleavage assays showed more robust hairpin and nicked product 
formation in the RAG-2(1-405) complex than in the RAG-2(1-405, D/E352-405A) 
(Figure S3A). Similarly, nick kinetics of RAG-2(1-405) show more robust product 
formation that RAG-2(1-405, D/E352-405A) (Figure S3B, C). Additionally, as the active 
fraction of the AcID-mutated sample was higher, the assay was repeated without 
normalization for active fraction and the results remained the same. This leaves at least 
two plausible hypotheses: (1) The gain-of-function phenotype seen on the 
extrachromosomal assays with RAG-2(1-405, D/E352-405) is mediated by recognition of 
a factor that is not found in the biochemical reaction; (2) The biochemistry of this mode 
of inhibition is synthetically incompatible with the standard biochemical assays used to 
assay RAG activity. The first possibility is exciting in that it would narrow the 
possibilities of the elements that the AcID could be recognizing. It is however, unlikely 
as the original 388/405A18 mutation was characterized in the context of the full-length 
protein. The second possibility is more difficult to assess. Future biochemical 
experiments could use the 388/405A18 mutation in the context of RAG truncation and the 
D/E352-405A mutation in the context of full-length RAG-2 to determine whether the 





















Supplementary Figure 3. Biochemical analysis of the acidic inhibitory domain 
mutation in the absence of noncore RAG-2 
(A) Coupled cleavage. Complexes of cRAG-1ct and the indicated RAG-2 were incubated 
in the presence of radiolabeled 12-RSS and unlabeled 23-RSS substrate to assess coupled 
cleavage over time as indicated. Nick indicates the position of the nicked product, while 
Hairpin indicates the position of the hairpin product. 
(B) Assay for RSS nicking. Reactions contained 1.5 nM cRAG-1ct/RAG-2(1-405) and 
12-RSS substrate HL44/45 at 10, 20, 40, or 60 nM. Accumulation of nicked product 
(Nick) was assayed at the indicated times. 


















NIH3T3 and HEK 293T cells were grown in Dulbecco’s modified Eagle’s medium 
supplemented with 10% fetal bovine serum (FBS) and 1X Penicillin-Streptomycin-
Glutamine (PSG). R2K3 and 63-12 lines were propagated in RPMI1640 supplemented 
with 10% FBS, 50 µM 2-mercaptoethanol, 1X PSG, 0.7X MEM non-essential amino 
acids solution, 1 mM sodium pyruvate, 10 mM HEPES. R2K3 cells with integrated 
PMX-INV recombination substrate were kindly provided by Dr. Barry Sleckman (Weill 
Cornell Medicine) (Gapud et al. 2011). All cells were maintained at 37°C in 5% CO2.  
 
Antibodies 
Commercial antibodies against the following proteins were used in this study: actin 
(clone AC-40, Sigma Aldrich, Cat#A3853); c-myc (clone 9E10, Santa Cruz 
Biotechnology, Cat#sc-40); RAG-1 (Abcam, Cat#ab172637); H3K4me3 (Active motif, 
cat#39915); sheep anti mouse secondary (GE Healthcare, Cat#NA931). The RAG-2 
antibody was kindly provided by Dr. David Schatz (Yale University). Immunoblot 
incubations were performed in 5% nonfat dry milk in PBST (1X PBS, 0.1% Tween). 
 
Expression constructs 
RAG-1 and RAG-2, tagged at the N terminus with maltose-binding protein (MBP) tag 
and at the C-terminus with a c-myc epitope and a polyhistidine sequence, were expressed 
in the vectors pcDNA1 and pcDNA3.1 respectively. Methods and oligonucleotide 
sequences used to generate RAG-2 variants are given in Table 1. For GeneArt String 
(Thermo Fisher) constructs, endogenous PasI and PflMI restriction sites were used. 
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Truncation mutations were introduced by PCR using the forward primer indicated as 
RAG-2 truncation F and appropriate reverse primers followed by cleavage with BamHI 
and EcoRI.  
 



































































































































































































PCR F: GCTCGGATCCCGGGTACC 
RAG-2(1-351) R PCR R: GAATTCAGAGCATCTCAAAGTATAGAAATA 
RAG-2(1-387) R PCR R: GAATTCACTGAAACAAAATTCCTCTGAG 
RAG-2(1-405) R PCR R: GAATTCATCTTCATTGTAGGTGTCAAATTC 
RAG-2(1-405, 
D/E352-405A) R 
PCR R: GAATTCAGCTGCATTGTAGGTGGCAAA 
 
 
Assays for exogenous rearrangement 
Extrachromosomal rearrangement assays were performed with 10 µg each of MBP-RAG-
1-myc-his (full length) and MBP-RAG-2-myc-his (wild-type or variant, as indicated), 
and 4 µg either pJH200 or pJH290, described previously(Hesse et al. 1987). Plasmids 
were transfected into NIH3T3 cells in a 10 cm dish with TransIT-LT1 (Mirus, Cat#MIR 
2300) or Lipofectamine 20000 (Thermo Fisher, Cat#11668-019) per manufacturer’s 
protocol. Recombination efficiency was similar with both protocols (results not shown). 
After 48 hours, the cell pellet was divided into thirds, one for storage, one for DNA 
isolation, and one for protein extraction. Plasmid DNA was extracted by a modified Hirt 
extraction (Qiagen, Cat#27104) per manufacturer’s protocol. DNA (3 µL, about 40 µg) 
was transformed into 50 µL DH5α Max Efficiency cells (Thermo Fisher, Cat#18258012) 
per manufacturer’s protocol. 1.7% of the transformation mixture was plated on LB agar 
containing 50 µg / mL ampicillin and the rest was plated on LB agar containing 50 µg / 
mL ampicillin and 20 µg / mL chloramphenicol. Plates containing ampicillin alone were 
scored after 16 hours at 37 °C, while plates with ampicillin and chloramphenicol were 
scored at 20 hours. Protein extraction was performed by addition of 150 µL of boiling 





For western blots, 60-90 µg protein (calculated using BioRad DC Protein Assay, 
Cat#500-0116) was loaded on an 8% SDS-PAGE gel and transferred to a 0.45 µm 
nitrocellulose membrane (Bio-Rad, Cat#1620115). Membranes were blocked at least 45 
min with 5% milk in PBST [1X PBS, 0.1% Tween]. 
 
Assays for endogenous recombination 
The retroviral vector pCLIP2A (Pomerantz et al. 2002) was programmed to coexpress 
puromycin N-acetyl transferase and RAG-2 variants. The RAG-2 cassettes were 
amplified from the corresponding pcDNA3.1 subclones by PCR using primers indicated 
in Table 1. Viral particles were generated by cotransfection of pCLIP2A constructs and 
pCL-Eco into 293T cells and concentrated by centrifugation. The B progenitor cell lines 
63-12 and R2K3 were infected by spin inoculation in the presence of 10 µg/mL 
polybrene. Cells were maintained under selection with 1 µg/mL puromycin for 21 - 25 
days. Recombination was induced in R2K3 cells (10 ml at 106 cells/ml) by addition of 
STI-571 (3 mM stock in DMSO) to a concentration of 3 µM for 48 or 96 hr. 
Genomic DNA was isolated from approximately 106 cells (Qiagen DNeasy) and DH-to-JH 
or Vκ-to-Jκ rearrangements were detected by PCR. Rearrangements were amplified from 
100 ng genomic DNA template by PCR using primers and annealing temperatures 
indicated in Table 2. RAG-1 was amplified for purposes of normalization from 30 ng 
genomic DNA template. Reaction products were fractionated by electrophoresis through 
1% agarose, transferred to Hybond N+ membranes (GE Healthcare) and detected by 
hybridization to radiolabeled probes defined in Table 2. 
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Table 2. Primers and probes used to assay rearrangement in B-cell progenitors 
Primer Anneal/Hybridization 
(°C) 
Sequence 5’ to 3’ 
DSP2 F 65 Anneal ATGGCCCCTGACACTCTGCACTGCT 
DFL16.1 F 65 Anneal ACACCTGCAAAACCAGAGACCATA 
Jh4 R 65 Anneal AAAGACCTGGAGAGGCCATTCTTACC 
Jh probe 61 Hybridization CTTACCTGAGGAGACGGTGAC 
IgKv F 65 Anneal GSTTCASWGGCAGTGGRTCTGG 
Mar35 R 65 Anneal AACACTGGATAAAGCAGTTTATGCCCTTTC 
IgK probe 58 Hybridization GCTCATTATCAGTTGACGTGGC 
RAG1 F Anneal GCATCTATTCTGTAGGATCTGC 
RAG1 R Anneal AAACAATGTCAAGCAGACAGCC 
Imu F 60 Anneal AATACCCGAAGCATTTACAGTGACT 
Imu R 60 Anneal AAGATTTGTGAAGCCGTTTTGACCA 
Mu0 F 60 Anneal GTGCAGGTCCCTCTCTTGTT 
Mu0 R 60 Anneal GACATTGCATCCACCCTTCT 
ACTB F 61 Anneal TGACGTGGACATCCGCAAAG 
ACTB R 61 Anneal CTGGAAGGTGGACAGCGAGG 
 
 
Assays for germline transcription 
RNA was isolated from R2K3 cells at 48 hours after arrest by STI-571 and cDNA was 
synthesized by random hexamer priming from total RNA. Sequences corresponding to Iµ 
or µ0 transcripts were detected by PCR using primers indicated in Table 2. Amplification 
of cDNA for actin beta (ACTB) was performed as a control (Liu et al. 2015). 
 
Chromatin immunoprecipitation 
Transduced B progenitor cells were treated with 3 µM STI571 for 21 hr. Chromatin 
immunoprecipitation (ChIP) was performed as described for RAG-1 and RAG-2 (Ji et al. 
2010) and for H3K4me3 (Chakraborty et al. 2009). Input and immunoprecipitated DNA 
were quantified performed by PicoGreen staining (Thermo Fisher). Each ChIP was 
performed in duplicate and each real-time PCR reaction was performed in duplicate. For 
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analysis of H3K4me3 enrichment 200 pg of DNA was used. The relative abundance of 
amplicons in the immunoprecipitated DNA relative to input was analyzed by real-time 
PCR using the primers listed in Table 3. The enrichment (IP/Input-corr) of RAG-1 or 
RAG-2 at specific regions was calculated as described (Ji et al. 2010). 
 
Table 3. Primers used in ChIP analyses 
Primer Sequence 5’-3’ Source 
γ-actin FP  GACACCCAACCCCGTGACG  
 
(Subrahmanyam et al. 
2012) 
γ-actin RP  GCGGCCATCACATCCCAG 
Cγ3 FP  TGGACAAACAGAAGTAGACATGGGTC 
Cγ3RP  GGGGTTTAGAGGAGAGAAGGCAC 
DSP2s FP  TGTTACCTTACTTGGCAGGGATTT 
DSP2s RP  TGGGTTTTTGTTGCTGGATATATC 
DFL16.1 FP CAAAGCAGCCACCATCCAG  
 
(Chakraborty et al. 
2009) 
DFL16.1 RP GCAGCACGGTTGAGTTTCAG 
DQ52 FP CCCTGTGGTCTCTGACTGGTG 
DQ52 RP GATTTCTCAAGCCTCTCTACTTCCTC 
JH2 FP TACTTTGACTACTGGGGC 
JH2 RP CCCTAGTCCTTCATGACC 
Jκ1 FP TTGTACAGCCAGACAGTGGAG  
 
 








Jκ1 RP GCCACAGACATAGACAACGG 
Jκ2 FP CAGATTCTGGCACTCTCCAA 
Jκ2 RP ACTGAGCATGGTCTGAGCAC 
Jκ4 FP AGTGTGAAAGCTGAGCGAAA 
Jκ4 RP CACAGTGAGGACTATGACATGC 
Cκ FP GTGGAAGATTGATGGCAGTG 
Cκ RP GCTCATGCTGTAGGTGCTGT 
Fahd1 FP AGAGACCTTTCGCTGACCTC 
Fahd1 RP GGTCATGTGACCACCGACT 
Rik FP GTTTCCACCGGAAGTGCT 




The duplex oligonucleotides used in the biochemical assays were HL44/45 (12-RSS) and 
HL46/47 (23-RSS) (Shimazaki et al. 2012). Oligonucleotides were purified by gel 
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electrophoresis and extraction and end-labeled where indicated with 32P by T4 DNA 
polynucleotide kinase (New England Biolabs). 
 
Table 4. Oligonucleotide substrates for biochemical assays 












Core RAG-1 (cR1-MH), the core RAG-1ct variant (cR1ct-MH) or full-length RAG-1 
(flR1- MH) were co-expressed in HEK 293T cells with full-length RAG-2 (fR2-MH) or 
the corresponding RAG-2 mutants. RAG complexes were purified as described (Raval et 
al. 2008). Transfected 293T cells were harvested in PBS-EDTA [1X PBS, 2 mM EDTA] 
and pelleted at 500 g at 4°C for 5 minutes. The supernatant was aspirated and cell pellets 
were resuspended in 7ml buffer R [25 mM HEPES (pH 7.4), 150 mM KCl, 2 mM DTT, 
1.04 mM aminoethyl-benzenesulfonyl fluoride, 0.8 μM aprotinin, 40 nM bestatin, 14 nM 
E-64, 20 nM leupeptin, 15 nM pepstatin A and 10% glycerol]. Cell suspensions were 
placed in a 50% ethanol dry ice bath and subjected to 3 rounds of sonication in a Branson 
Digital Sonifier 450. Each round of sonication was performed at 23% amplitude for 1.5 
12 minutes, with 30 second intervals of sonication followed by a 10 second rest between 
intervals. The lysate was clarified by centrifugation at 46,000 g in an SW55Ti rotor at 
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4°C for 30 min and the supernatant was loaded onto 1 ml amylose resin that had been 
equilibrated with buffer R. The column was washed once with 5 ml buffer R and once 
with 5 ml buffer R lacking protease inhibitors. Protein was eluted with 10 mM maltose in 
buffer R lacking protease inhibitors and then dialyzed against buffer R. Aliquots were 
snap frozen and stored at -80˚C. 
 
Burst kinetic analysis 
Varying nominal concentrations of RAG protein were combined with 200 nM total 
radiolabeled HL44/45 in binding buffer containing 1% glycerol (reaction volume 10 µl) 
and incubated for 20 min at 37°C, at which time MgCl2 was added to 5 mM. Incubation 
was continued for an additional 30 min at 37°C. Reactions were stopped by addition of 
10 µl 90% formamide-TBE and heated for 5 min at 95°C. Products were fractioned by 
electrophoresis on a 15% polyacrylamide-urea gel, visualized by a phosphorimager 
quantified using ImageQuantNL. The active fraction of each RAG preparation was 
determined by (1) plotting accumulation of nicked product ([N]) as a function of time for 
each concentration of total RAG; (2) extrapolating rates to zero time, thereby obtaining 
the initial burst of nicked product formation ([N]0) at each nominal RAG concentration; 
and (3) expressing [N]0 as a linear function of nominal RAG concentration:  
[𝑁]0 = 𝑓𝑎   [𝑅𝐴𝐺]𝑇 + 𝑏 
where [RAG]T is the total (nominal) concentration of RAG, assuming a tetrameric 
stoichiometry of (RAG-1)2(RAG-2)2, and fa is the fraction of [RAG]T that is active (Yu 




Assays for coupled cleavage 
RAG (1 nM active tetramer, as determined by burst kinetic analysis) was combined in 
binding buffer with 5 nM HL44/45, 5 nM HL46/47 and varying concentrations of a 
peptide corresponding to the amino-terminal 21 residues of histone H3, either 
trimethylated at lysine 4 (H3K4me3; Anaspec, 64194) or unmethylated (H3K4me0; 
Anaspec, 61701), in a reaction volume of 10 µl. After incubation for 20 min at 37°C, 
MgCl2 was added to 5 mM and incubation was continued for an additional 1 hr. 
Reactions were stopped and products were analyzed as above. 
 
Assays for DNA nicking 
RAG (1 nM active tetramer, as determined by burst kinetic analysis) was combined in 
binding buffer with 5 nM HL44/45 and varying concentrations of a peptide 
corresponding to the amino-terminal 21 residues of histone H3, either trimethylated at 
lysine 4 (H3K4me3; Anaspec, 64194) or unmethylated (H3K4me0; Anaspec, 61701), in a 
reaction volume of 10 µl. After incubation for 20 min at 37°C, MgCl2 was added to 5 
mM and incubation was continued for an additional 30 min. Reactions were stopped and 
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